Processing 00000000.tx.1: Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression Jessie Theuns1, Jacques Remacle2, Richard Killick3, Ellen Corsmit1, Krist'l Vennekens1, Danny Huylebroeck2, Marc Cruts1 and Christine Van Broeckhoven1,* 1Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Antwerp (UIA), Antwerpen, Belgium, 2Department of Developmental Biology, Flanders Interuniversity Institute for Biotechnology (VIB) and Laboratory of Molecular Biology (CELGEN), University of Leuven (KUL), Leuven, Belgium and 3The Institute of Psychiatry, Department of Neuroscience, London, UK Received December 19, 2002; 

Phrase: "Alzheimer-associated C allele of the promoter polymorphism -22C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]

Phrase: ">T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a critical neuron-specific decrease of presenilin 1 expression Jessie Theuns1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "Jacques Remacle2,"

Phrase: "Richard Killick3,"

Phrase: "Ellen Corsmit1,"

Phrase: "Krist'l Vennekens1,"

Phrase: "Danny Huylebroeck2,"

Phrase: "Marc Cruts1"

Phrase: "and"

Phrase: "Christine Van Broeckhoven1,"

Phrase: "* 1Department of Molecular Genetics,"

Phrase: "Flanders Interuniversity Institute for Biotechnology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "(VIB"

Phrase: ")"

Phrase: ","

Phrase: "University of Antwerp (UIA),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Antwerpen,"

Phrase: "Belgium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "2Department of Developmental Biology,"

Phrase: "Flanders Interuniversity Institute for Biotechnology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "(VIB)"

Phrase: "and"

Phrase: "Laboratory of Molecular Biology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "(CELGEN"

Phrase: ")"

Phrase: ","

Phrase: "University of Leuven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "(KUL"

Phrase: ")"

Phrase: ","

Phrase: "Leuven,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "and"

Phrase: "3The Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Department of Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "December 19,"

Phrase: "2002"

Phrase: ";"
Processing 00000000.tx.2: Accepted February 10, 2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We, amongst others, have shown that CC homozygosity at the -22C>T promoter polymorphism in presenilin 1 (PSEN1) is associated with increased risk for Alzheimer's disease (AD). 

Phrase: "Accepted February 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We,"

Phrase: "amongst others,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that CC homozygosity at the -22C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019904:Homozygosity [Organism Attribute]

Phrase: ">T promoter polymorphism in presenilin 1 (PSEN1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.3: Also, studies in AD brains suggested that CC homozygosity increased the risk for AD by increasing the A load. 

Phrase: "Also,"

Phrase: "studies in AD brains"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that CC homozygosity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygosity [Organism Attribute]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the risk for AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "by increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the A load."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]
Processing 00000000.tx.4: We characterized the PSEN1 promoter by deletion mapping, and analysed the effect of the -22C and -22T alleles on the transcriptional activity of PSEN1 in a transient transfection system. 

Phrase: "We"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the PSEN1 promoter by deletion mapping,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "analysed"

Phrase: "the effect of the -22C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and -"

Phrase: "22T alleles on the transcriptional activity of PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Alleles [Gene or Genome]

Phrase: "in a transient transfection system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.5: We showed a neuron-specific 2-fold decrease in promoter activity for the -22C risk allele, which in homozygous individuals would lead to a critical decrease in PSEN1 expression. 

Phrase: "We"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a neuron-specific 2-fold decrease in promoter activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "for the -22C risk allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "which in homozygous individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0019904:Homozygous [Organism Attribute]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "would"

Phrase: "lead to a critical decrease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1511545:Critical [Qualitative Concept]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in PSEN1 expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]
Processing 00000000.tx.6: The deletion mapping suggested that the 13bp region (-33/-20) spanning the -22C>T polymorphism harbours a binding site for a negative regulatory factor. 

Phrase: "The deletion mapping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1283195:Mapping [Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the 13bp region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(-33/-20"

Phrase: ")"

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the -22C"

Phrase: ">T polymorphism harbours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0475311:Harbour [Manufactured Object]

Phrase: "a binding site for a negative regulatory factor."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0005456:Binding Site [Receptor]
   770   C0682969:Binding Site [Amino Acid Sequence]
   744   C0205145:Site [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
Processing 00000000.tx.7: This factor has a higher affinity for the -22C risk allele and is strongly dependent on downstream sequences for cell-type-specific expression differences. 

Phrase: "This factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "has"

Phrase: "a higher affinity for the -22C risk allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "is"

Phrase: "strongly dependent on downstream sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "for cell-type-specific expression differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1705241:*Difference [Quantitative Concept]
   771   C1705242:Difference [Qualitative Concept]
   721 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.8: Together, these studies provide evidence that the increased risk for AD associated with PSEN1 may result from genetic variations in the regulatory region, leading to altered expression levels of PSEN1 in neurons.  

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the increased risk for AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "associated with PSEN1"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "may"

Phrase: "result from genetic variations"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   833   C0042333:Variations, Genetic [Natural Phenomenon or Process]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0205419:variations [Qualitative Concept]
   770   C0314603:Genetic [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "in the regulatory region,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "leading to altered expression levels of PSEN1"
Meta Candidates (Total=19; Excluded=8; Pruned=0; Remaining=11)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   750   C0428255:lead levels [Laboratory or Test Result]
   750   C0456947:Level 1 [Intellectual Product]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0332152:Leading [Temporal Concept]
   744   C0392747:Altered [Functional Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   744   C1522538:Leading [Functional Concept]
   737   C3244092:expression level [Idea or Concept]
   734 E C0524167:Lead level [Laboratory Procedure]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C0456079:Level [Classification]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1547707:Level [Geographic Area]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C2946261:Level [Pharmacologic Substance]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Alzheimer's disease (AD) is the most common form of senile dementia and is caused by progressive degeneration of the central nervous system. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "the most common form of senile dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "caused by progressive degeneration of the central nervous system."
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   810   C3277687:Central nervous system degeneration [Finding]
   790   C0927232:Central Nervous System [Body System]
   790   C1269563:Central nervous system [Body System]
   764   C0027763:Nervous System [Body System]
   764   C0422837:NERVOUS SYSTEM [Finding]
   764   C1269560:Nervous system [Body System]
   762   C1265852:Central degeneration [Pathologic Function]
   756   C3275607:Neurologic degeneration [Finding]
   742   C0011164:Degeneration [Pathologic Function]
   742   C0027769:Nervous [Sign or Symptom]
   742   C0205099:Central [Spatial Concept]
   742   C0205329:Progressive [Functional Concept]
   742   C0449913:System [Functional Concept]
   742   C0599851:Nervous [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   742   C1879652:Central - [Laboratory Procedure]
   742   C1880269:Degeneration [Functional Concept]
   709 E C0205494:Neurologic [Qualitative Concept]
   708   C0015127:cause [Functional Concept]
   708   C1524003:Cause [Conceptual Entity]
   704   C0027746:Nerve Degeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.10: There is substantial evidence that genetic factors play a role in AD. 

Phrase: "There"

Phrase: "is"

Phrase: "substantial evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.11: The genetic contribution to AD is particularly strong in cases with the early-onset form of the disease (onset<65 years; EOAD). 

Phrase: "The genetic contribution to AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "is"

Phrase: "particularly strong in cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442821:Strong [Qualitative Concept]

Phrase: "with the early-onset form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]
   734   C1833334:Early-onset [Finding]

Phrase: "of the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "<65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "; EOAD"

Phrase: ")."
Processing 00000000.tx.12: A positive family history was observed for 60% of EOAD cases and in 10% of the familial cases AD is inherited as an autosomal-dominant trait (1). 

Phrase: "A positive family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C0241889:Family history [Finding]
   901   C1705495:Family History [Idea or Concept]
   827   C0015576:Family [Family Group]
   827   C0019664:History [Occupation or Discipline]
   827   C0019665:history [Intellectual Product]
   827   C0262512:History, NOS [Organism Attribute]
   827   C0262926:History [Finding]
   827   C1704727:Family [Conceptual Entity]
   827   C1705255:History [Conceptual Entity]
   827   C2004062:History [Finding]
   755 E C0241888:Familial [Functional Concept]
   755 E C1552658:Historical [Idea or Concept]
   755 E C1552723:Historical [Idea or Concept]

Phrase: "was"

Phrase: "observed for 60% of EOAD cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0868928:Cases [Functional Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "and in 10% of the familial cases AD"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0015576:familial [Family Group]
   744   C0241888:Familial [Functional Concept]
   744   C0868928:Cases [Functional Concept]
   744   C1515981:And [Idea or Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "is"

Phrase: "inherited as an autosomal-dominant trait"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178491:autosomal dominant trait [Organism Attribute]
   790   C0443147:Autosomal dominant [Intellectual Product]
   753   C0439660:Inherited [Functional Concept]
   753   C0596142:autosomal [Cell Component]
   753   C0599883:Trait [Organism Attribute]
   753   C1527180:Dominant [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Three genes have been identified that together explain 1850% of all autosomal dominant EOAD families (26). 

Phrase: "Three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "explain"

Phrase: "1850% of all autosomal dominant EOAD families"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0443147:Autosomal dominant [Intellectual Product]
   748   C0015576:Families [Family Group]
   748   C0596142:autosomal [Cell Component]
   748   C1527180:Dominant [Functional Concept]
   748   C1704727:Family [Conceptual Entity]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.14: In addition the E4 allele of the apolipoprotein E gene (APOE4) was shown to explain 12% of AD in the general population, with a 2.3-fold increase of the E4 allele in EOAD patients (7,8). 

Phrase: "In addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the E4 allele of the apolipoprotein E gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C3642141:Apolipoprotein E4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "(APOE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "12% of AD"

Phrase: "in the general population,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "with a 2.3-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "of the E4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "in EOAD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.15: The most frequently mutated gene in autosomal dominant EOAD is presenilin 1 (PSEN1) with the majority of mutations being missense mutations (http://molgen-www.uia.ac.be/ADMutations/) (2,9). 

Phrase: "The most frequently mutated gene in autosomal dominant EOAD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0017342:Dominant gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "with the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "of mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "being"

Phrase: "missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//molgen-www.uia.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1412573:AC [Gene or Genome]
   812   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3539770:AC [Gene or Genome]

Phrase: "be/"

Phrase: "ADMutations/"

Phrase: ")"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.16: Missense mutations in PSEN1 were shown to lead to autosomal-dominant EOAD by pathways dependent upon the production of increased amounts of the amyloidogenic A42 peptide (10). 

Phrase: "Missense mutations in PSEN1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0599155:Mutations, Missense [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lead to autosomal-dominant EOAD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0443147:Autosomal dominant [Intellectual Product]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0596142:autosomal [Cell Component]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1527180:Dominant [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "dependent upon the production of increased amounts of the amyloidogenic A42 peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0851827:Dependent [Qualitative Concept]
   736   C1701901:Dependent [Qualitative Concept]
   736   C3244310:dependent [Functional Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.17: Also, effective inhibition (up to 50% of the normal level) of PSEN1 expression in cultured cells by an anti-sense RNA approach resulted in increased A42 production (11). 

Phrase: "Also,"

Phrase: "effective inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "("

Phrase: "up to 50%"

Phrase: "of the normal level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "of PSEN1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "by an anti-sense RNA approach"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449445:Approach [Spatial Concept]
   756   C0080124:Anti-Sense RNA [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "resulted in increased A42 production"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033268:production [Occupational Activity]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.18: On the other hand, in neuronal cell cultures derived from PSEN1 deficient mice, APP processing into A was prevented (12). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "in neuronal cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0007585:Cell Cultures [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Cultures [Idea or Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "derived from PSEN1 deficient mice,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C3657569:presenilin 1, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PRESENILIN 1 [Gene or Genome]
   753   C0011155:Deficient [Functional Concept]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   753   C1441547:Derived [Qualitative Concept]
   753   C1636779:% deficient [Quantitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "APP processing into A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.19: Together, these observations suggested that variable expression levels of PSEN1 modulate A production. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that variable expression levels of PSEN1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C1868500:Variable expression [Finding]
   757   C0456947:Level 1 [Intellectual Product]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Levels [Qualitative Concept]
   745   C3244092:expression level [Idea or Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.20: Previously, we reported a potential role for the PSEN1 promoter in increased risk for EOAD in a Dutch population-based study (13). 

Phrase: "Previously,"

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a potential role for the PSEN1 promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in increased risk"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   861   C0035647:Risk [Qualitative Concept]
   861   C0205217:Increased [Quantitative Concept]
   861   C0442805:Increased [Functional Concept]
   789 E C1517378:Gain [Quantitative Concept]
   768 E C0439661:Acquired [Temporal Concept]
   768 E C0442808:Increasing [Functional Concept]
   768 E C1301820:Obtain [Functional Concept]
   768 E C1706701:Acquire [Activity]
   768 E C3245488:acquired [Intellectual Product]

Phrase: "for EOAD"

Phrase: "in a Dutch population-based study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1709599:Population Based Study [Research Activity]
   875   C0681876:Population Study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.21: Significant association was found with the promoter polymorphism -22C>T [numbering relative to the major transcription initiation site (TIS) P1 reported by Pastorcic and Das (14); formerly, this polymorphism was reported as -48C>T (2) with numbering relative to the TIS t2 reported by Rogaev et al. (15)]. 

Phrase: "Significant association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "found with the promoter polymorphism -22C"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0032529:Polymorphism [Genetic Function]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0150312:Found [Quantitative Concept]
   753   C1882417:Polymorphism [Qualitative Concept]
   719 E C0243095:Find [Finding]

Phrase: ">T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "["

Phrase: "numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "relative to the major transcription initiation site (TIS) P1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "reported by Pastorcic"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "Das (14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   861   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "; formerly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415386:FORMERLY [Gene or Genome]

Phrase: "this polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "as -48C"

Phrase: ">T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "with numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "relative to the TIS t2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "reported by Rogaev et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(15"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.22: The most frequent allele -22C was associated with an increased risk for EOAD (OR=2.6) due to significant overrepresentation of the CC genotype in patients, independent of the APOE4 genotype (13). 

Phrase: "The most frequent allele -22C"

Phrase: "was"

Phrase: "associated with an increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for EOAD"

Phrase: "(OR=2.6"

Phrase: ")"

Phrase: "due to significant overrepresentation"

Phrase: "of the CC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "in patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "independent of the APOE4 genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.23: In a systematic screen of the PSEN1 regulatory region we identified two additional polymorphisms (-2128G>A and -2797I/D) associated with increased risk for EOAD (16). 

Phrase: "In a systematic screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220908:screen [Health Care Activity]
   861   C1305399:screen [Functional Concept]
   861   C1705053:Screen [Medical Device]

Phrase: "of the PSEN1 regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two additional polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(-2128G"

Phrase: ">"

Phrase: "A"

Phrase: "and -"

Phrase: "2797I/"

Phrase: "D)"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for EOAD"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.24: All three promoter polymorphisms showed a high degree of linkage disequilibrium allowing the identification of a risk haplotype (-22C/-2128G/-2797D). 

Phrase: "All three promoter polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a high degree of linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "the identification of a risk haplotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0150323:Risk identification [Health Care Activity]
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "(-22C/-2128G/-2797D"

Phrase: ")."
Processing 00000000.tx.25: Homozygosity for the risk haplotype was significantly higher in EOAD patients than in controls (P=0.03). 

Phrase: "Homozygosity for the risk haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygosity [Organism Attribute]

Phrase: "was"

Phrase: "significantly higher in EOAD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(P=0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.26: In addition, we observed two heterozygous mutations (-254C>G and -2792A>G) in two patients homozygous for the risk haplotype (16). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "two heterozygous mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(-254C"

Phrase: ">G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and -"

Phrase: "2792A"

Phrase: ">G) in two patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "homozygous for the risk haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.27: Each polymorphism and mutation involved consensus sequences of transcriptional regulatory elements and therefore might modulate PSEN1 transcription. 

Phrase: "Each polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "consensus sequences of transcriptional regulatory elements"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0079160:Sequences, Consensus [Nucleotide Sequence]
   767   C0314642:Regulatory sequence [Nucleotide Sequence]
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C0376298:Consensus [Social Behavior]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "might"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "PSEN1 transcription."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040649:Transcription [Genetic Function]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]
Processing 00000000.tx.28: Indeed, reporter gene data using luciferase demonstrated that the -254G mutation decreased PSEN1 transcriptional activity by 30% in neuroblastoma cells (17). 

Phrase: "Indeed,"

Phrase: "reporter gene data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0206414:Reporter Gene [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the -254G mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "PSEN1 transcriptional activity by 30%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.29: Recently, the association between -22CC and AD was replicated in a UK population of EOAD and late-onset AD patients (P=0.04) (18). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the association between -22CC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AD"

Phrase: "was"

Phrase: "replicated in a UK population of EOAD"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0032659:Population [Quantitative Concept]
   748   C0205173:replicated [Functional Concept]
   748   C1257890:Population [Population Group]
   714 E C0205341:Replicate [Functional Concept]
   714 E C1883725:Replicate [Qualitative Concept]

Phrase: "and"

Phrase: "late-onset AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "(P=0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.30: Moreover, this study showed a phenotypic correlation with A40, A42 and total A load in AD brains, suggesting that the C allele of the -22C>T polymorphism in the PSEN1 promoter increased the risk of AD by altering PSEN1 expression and thereby influencing A load. 

Phrase: "Moreover,"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a phenotypic correlation with A40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "A42"

Phrase: "and"

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "A load in AD brains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1550025:Load [Idea or Concept]
   760   C1704782:Load [Manufactured Object]
   760   C1708715:Load [Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the C allele of the -22C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: ">T polymorphism in the PSEN1 promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "by altering PSEN1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "thereby"

Phrase: "influencing"

Phrase: "A load."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]
Processing 00000000.tx.31: Here, we performed additional studies of the proximal PSEN1 promoter, focusing on the functionality of the -22C variant in relation to AD.  

Phrase: "Here,"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "additional studies of the proximal PSEN1 promoter,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "focusing on the functionality of the -22C variant"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0000936:focusing [Clinical Attribute]
   744   C0205419:Variant [Qualitative Concept]
   744   C2981153:Focusing [Finding]
   711 E C0205234:Focus [Spatial Concept]
   711 E C1285542:focus [Functional Concept]

Phrase: "in relation to AD."
Processing 00000000.tx.32: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Alternatively transcription initiation of PSEN1 in multiple tissues Two alternative initiated transcripts of PSEN1 have been reported (15). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alternatively transcription initiation of PSEN1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   753   C0589507:Initiation [Mental Process]
   753   C1704686:Initiation [Functional Concept]

Phrase: "in multiple tissues Two alternative initiated transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.33: The major transcript starts at exon 1A and is present in multiple tissues. 

Phrase: "The major transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "starts at exon 1A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439659:Start [Temporal Concept]
   770   C0450344:1A [Intellectual Product]
   770   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "is"

Phrase: "present in multiple tissues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.34: The transcript starting at exon 1B has been detected only once in a colon adenocarcinoma cell line (15) and has not been studied since. 

Phrase: "The transcript starting at exon 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0439659:Start [Temporal Concept]

Phrase: "has"

Phrase: "been"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "once in a colon adenocarcinoma cell line"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0007600:Cell Line [Cell]
   778   C0338106:Colon Adenocarcinoma [Neoplastic Process]
   778   C1510779:Adenocarcinoma Cell [Cell]
   748   C0001418:Adenocarcinoma [Neoplastic Process]
   748   C0007634:Cell [Cell]
   748   C0009368:Colon [Body Part, Organ, or Organ Component]
   748   C0205132:Line [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1281569:Colon [Body Part, Organ, or Organ Component]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1720092:Once [Intellectual Product]
   748   C1948045:Once [Temporal Concept]
   748   C1948049:Cell [Spatial Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "since."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711239:Since [Temporal Concept]
Processing 00000000.tx.35: We examined in more detail both transcripts in different tissues and cell types. 

Phrase: "We"

Phrase: "examined in more detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332128:Examined [Finding]
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "both transcripts in different tissues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.36: RTPCR analysis of the same amount of poly (A) RNA showed that exon 1A transcripts were indeed present at high levels in brain, liver, testis, colon and lymphoblasts (Fig.1A). 

Phrase: "RTPCR analysis of the same amount of poly (A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0599161:RT-PCR [Molecular Biology Research Technique]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: ")"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that exon 1A transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "indeed"

Phrase: "present at high levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0150312:Present [Quantitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "testis,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "colon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009368:Colon [Body Part, Organ, or Organ Component]
  1000   C1281569:Colon [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0229613:Lymphoblasts [Cell]
  1000   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.37: Increasing the amount of DNA polymerase enabled us to show that exon 1B transcripts were also present in all these tissues though at lower levels, with a significantly lower expression in brain and almost undetectable expression in liver (Fig.1B). 

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of DNA polymerase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that exon 1B transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "also"

Phrase: "present in all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "these tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "though at lower levels,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0441889:Levels [Qualitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "with a significantly lower expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "almost undetectable expression in liver"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.38: RTPCR analysis of comparable levels of total RNA of human neuroblastoma and kidney cells also showed lower expression of exon 1B versus exon 1A transcripts (data not shown). 

Phrase: "RTPCR analysis of comparable levels of total RNA of human neuroblastoma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0599161:RT-PCR [Molecular Biology Research Technique]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "kidney cells also"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0553257:kidney cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "lower expression of exon 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "versus"

Phrase: "exon 1A transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.39: RNA ligase-mediated rapid amplification of cDNA ends (RLM-5'RACE) in different tissues and cell types using an exon 3 primer confirmed these results. 

Phrase: "RNA ligase-mediated rapid amplification of cDNA ends"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0920648:RNA amplification [Molecular Biology Research Technique]
   744   C1517480:Amplification [Molecular Biology Research Technique]
   744   C1521871:Amplification [Phenomenon or Process]
   744   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "(RLM-5'RACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034510:Race [Population Group]
   827   C1706779:RACE [Gene or Genome]

Phrase: ")"

Phrase: "in different tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an exon 3 primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "these results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.40: Sequence analysis of 20 RLM-5'RACE cloned transcripts for each of the eight different tissues and cell types (160 clones in total) revealed the presence of multiple TISs for PSEN1 exon1A as reported (14,15). 

Phrase: "Sequence analysis of 20 RLM-5'"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0936012:Analysis [Research Activity]
   753   C1519249:Sequence [Functional Concept]
   753   C1524024:analysis [Functional Concept]

Phrase: "RACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034510:Race [Population Group]
  1000   C1706779:RACE [Gene or Genome]

Phrase: "cloned transcripts for each of the eight different tissues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(160 clones in total"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0009013:Clones [Cell]
   737 E C1522642:Clone [Tissue]

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of multiple TISs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for PSEN1 exon1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "as reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.41: In all tissues and cell types the TIS of the majority (93.4%) of exon 1A transcripts is located at (+1) or downstream of P1 (Table 1) (10). 

Phrase: "In all tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "the TIS of the majority"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0949639:Transcription Initiation Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   778   C2945843:Site of [Qualitative Concept]
   748   C0040649:Transcription [Genetic Function]
   748   C0205145:Site [Spatial Concept]
   748   C0589507:Initiation [Mental Process]
   748   C1515974:Site [Body Location or Region]
   748   C1704686:Initiation [Functional Concept]
   748   C2825164:Site [Spatial Concept]

Phrase: "(93.4%"

Phrase: ")"

Phrase: "of exon 1A transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "located"

Phrase: "at (+1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ")"

Phrase: "or downstream of P1 (Table 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0445159:P1.1 [Intellectual Product]
   753   C0039224:Table [Manufactured Object]
   753   C0522506:Downstream [Spatial Concept]
   753   C1706073:Table [Medical Device]
   753   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.42: Interestingly, 6.6% of the transcripts started 611bp upstream of P1, suggesting that the true TIS of exon 1A might be located 11bp upstream of P1. 

Phrase: "Interestingly,"

Phrase: "6.6% of the transcripts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0442750:6/6 [Finding]
   760   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "started"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272689:Started [Qualitative Concept]
   966 E C0439659:Start [Temporal Concept]

Phrase: "611bp upstream of P1,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the true TIS of exon 1A"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0949639:Transcription Initiation Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   770   C2945843:Site of [Qualitative Concept]
   744   C0040649:Transcription [Genetic Function]
   744   C0205145:Site [Spatial Concept]
   744   C0589507:Initiation [Mental Process]
   744   C1515974:Site [Body Location or Region]
   744   C1704686:Initiation [Functional Concept]
   744   C2825164:Site [Spatial Concept]

Phrase: "might"

Phrase: "be"

Phrase: "located"

Phrase: "11bp upstream of P1."
Processing 00000000.tx.43: Also interesting was that 7% of the transcripts lacked the last 4bp of exon 1A. 

Phrase: "Also"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "was"

Phrase: "that 7% of the transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "the last 4bp of exon 1A."
Processing 00000000.tx.44: None of the RLM-RACE clones contained exon 1B, however preliminary RLM-RACE experiments using an exon 1B primer identified exon 1B transcripts in different tissues and cell types (data not shown). 

Phrase: "None of the RLM-RACE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034510:Race [Population Group]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C1706779:RACE [Gene or Genome]

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "contained exon 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450345:1B [Intellectual Product]

Phrase: "however preliminary RLM-RACE experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an exon 1B primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "exon 1B transcripts in different tissues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.45: The integrity of the RLM-RACE products of the different tissues and cell types was verified using -actin control primers. 

Phrase: "The integrity of the RLM-RACE products of the different tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0205266:integrity [Qualitative Concept]
   738   C0872403:integrity [Individual Behavior]
   738   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "actin control primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.46: Thirty-eight out of 40 clones analysed contained the full-length -actin 5' end and only two clones lacked 3 and 6bp, respectively. 

Phrase: "Thirty-eight out of 40 clones"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0009013:Clones [Cell]
   753   C0205454:Eight [Quantitative Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "analysed"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the full-length -actin 5' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0444930:End [Spatial Concept]
   804   C2746065:End [Temporal Concept]
   748 E C0205088:Terminal [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "only two clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "6bp,"

Phrase: "respectively."
Processing 00000000.tx.47: Therefore, we can conclude that variation in transcription initiation of PSEN1 is a gene-specific effect and is not due to general degradation of RNA. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "can"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that variation in transcription initiation of PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "a gene-specific effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "not due to general degradation of RNA."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0678226:Due to [Functional Concept]
           due
   774   C1257756:RNA Degradation [Genetic Function]
   774   C2984321:RNA degradation [Functional Concept]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205246:General [Spatial Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   748   C1518422:Not [Functional Concept]
   748   C1553889:General [Idea or Concept]
   748   C3146286:Due [Idea or Concept]
Processing 00000000.tx.48: View larger version (77K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(77K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.49: RTPCR analysis of PSEN1 exon 1A and 1B transcripts in different human tissues. 

Phrase: "RTPCR analysis of PSEN1 exon 1A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0599161:RT-PCR [Molecular Biology Research Technique]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "1B transcripts in different human tissues."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.50: Tissues are presented by: B, brain; 

Phrase: "Tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "are"

Phrase: "presented by"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0449450:Presented [Idea or Concept]
   799 E C0150312:Present [Quantitative Concept]

Phrase: ":"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.51: H, liver; 

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: ";"
Processing 00000000.tx.52: T, testes; 

Phrase: "T,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "testes"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0021358:Testes [Body Part, Organ, or Organ Component]
  1000   C0039597:Testes [Body Part, Organ, or Organ Component]
   966 E C0228018:teste [Body Part, Organ, or Organ Component]
   966 E C1278981:Testis [Body Part, Organ, or Organ Component]
   900 E C0205070:Testicular [Spatial Concept]
   884 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.53: C, colon, L, lymphoblast. 

Phrase: "C,"

Phrase: "colon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009368:Colon [Body Part, Organ, or Organ Component]
  1000   C1281569:Colon [Body Part, Organ, or Organ Component]

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "lymphoblast."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0229613:lymphoblast [Cell]
Processing 00000000.tx.54: (0) No RNA present in RT reaction; 

Phrase: "(0"

Phrase: ")"

Phrase: "No RNA present in RT reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.55: (-) negative control PCR reaction; 

Phrase: "(-"

Phrase: ")"

Phrase: "negative control PCR reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.56: (M) 100bp ladder. 

Phrase: "("

Phrase: "M)"

Phrase: "100bp ladder."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336762:Ladder [Manufactured Object]
Processing 00000000.tx.57: The DNA polymerase amount per PCR reaction is shown at the top of the gels. 

Phrase: "The DNA polymerase amount per PCR reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "is"

Phrase: "shown at the top of the gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C1704458:Top [Spatial Concept]
   714 E C1382104:Gel [Substance]
   714   C1547282:Show [Intellectual Product]
Processing 00000000.tx.58: No RT, no reverse transcriptase. 

Phrase: "No RT,"

Phrase: "no reverse transcriptase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1555029:Reverse [Idea or Concept]
   861   C2257077:transcriptase [Genetic Function]
Processing 00000000.tx.59: PSEN1 cDNA sequences from exons 1A3 and exons 1B3, respectively, are presented at the bottom of the graphs. 

Phrase: "PSEN1 cDNA sequences from exons 1A3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0162326:Sequences [Nucleotide Sequence]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "exons 1B3,"

Phrase: "respectively,"

Phrase: "are"

Phrase: "presented at the bottom of the graphs."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0449450:Presented [Idea or Concept]
   748   C0681493:graphs [Intellectual Product]
   748   C1511276:Bottom [Spatial Concept]
   748   C1552825:bottom [Idea or Concept]
   714 E C0150312:Present [Quantitative Concept]
   714 E C2698021:Graph [Conceptual Entity]
Processing 00000000.tx.60: Exon boundaries are marked by vertical lines and primers are presented by arrows. 

Phrase: "Exon boundaries"

Phrase: "are"

Phrase: "marked by vertical lines"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205128:Vertical [Spatial Concept]
   770   C0205132:lines [Spatial Concept]
   770   C0522501:Marked [Qualitative Concept]
   770   C1706089:Marked [Qualitative Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "presented by arrows."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.61: (A) Exon 1A amplification. 

Phrase: "(A) Exon 1A amplification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.62: (B) Exon 1B amplification.  

Phrase: "(B) Exon 1B amplification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.63: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.64: Transcription initiation sites (TIS) of the human PSEN1 exon 1A transcripts mapped by RLM-RACE in different tissues and cell types. 

Phrase: "Transcription initiation sites"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0949639:Transcription Initiation Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   827   C0040649:Transcription [Genetic Function]
   827   C0205145:Sites [Spatial Concept]
   827   C0589507:Initiation [Mental Process]
   827   C1704686:Initiation [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "(TIS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0949639:Transcription Initiation Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   827   C0040649:Transcription [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0589507:Initiation [Mental Process]
   827   C1515974:Site [Body Location or Region]
   827   C1704686:Initiation [Functional Concept]
   827   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "of the human PSEN1 exon 1A transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mapped by RLM-RACE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034510:Race [Population Group]
   770   C1706779:RACE [Gene or Genome]
   737   C0024779:Map [Manufactured Object]
   737   C1706473:Map [Conceptual Entity]

Phrase: "in different tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.65: The numbering is relative to the most upstream exon 1A TIS (P1 or +1) previously reported by Pastorcic and Das (14)  Deletion mapping of the PSEN1 regulatory region We constructed a deletion panel of the PSEN1 upstream region encompassing nucleotides -3501 to +1413 [numbering relative to P1 (14); Fig.2]. 

Phrase: "The numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "is"

Phrase: "relative to the most upstream exon 1A TIS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]

Phrase: "(P1 or +1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0445159:P1.1 [Intellectual Product]

Phrase: ")"

Phrase: "previously"

Phrase: "reported by Pastorcic"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "Das (14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   861   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "Deletion mapping of the PSEN1 regulatory region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1283195:Mapping [Activity]

Phrase: "We"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "a deletion panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "of the PSEN1 upstream region encompassing nucleotides -3501 to +1413"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   807   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C1418985:PRESENILIN 1 [Gene or Genome]
   807   C1883644:Upstream Region [Nucleotide Sequence]
   791   C0017446:Region [Geographic Area]
   791   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   791   C0205147:Region [Spatial Concept]
   791   C0522505:Upstream [Spatial Concept]
   791   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   720 E C0205276:Regional [Spatial Concept]
   720 E C1947913:Regional [Spatial Concept]

Phrase: "["

Phrase: "numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "relative to P1 (14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: "; Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "]."
Processing 00000000.tx.66: Transcriptional activity of the promoter constructs was analysed in transiently transfected HEK293 and N2a cells by measuring firefly luciferase activity. 

Phrase: "Transcriptional activity of the promoter constructs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "analysed in transiently transfected HEK293"

Phrase: "and"

Phrase: "N2a cells by measuring firefly luciferase activity."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.67: View larger version (16K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.68: Deletion mapping of functional PSEN1 promoter elements. 

Phrase: "Deletion mapping of functional PSEN1 promoter elements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1283195:Mapping [Activity]
Processing 00000000.tx.69: The upper horizontal line represents a detailed restriction map of plasmid B22 (27). 

Phrase: "The upper horizontal line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a detailed restriction map of plasmid B22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0024779:Map [Manufactured Object]
   748   C1706473:Map [Conceptual Entity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.70: Exons 1A (Ex 1A, +1 to +139) and 1B (Ex 1B, +373 to +779) of PSEN1 are represented by the respective black boxes. 

Phrase: "Exons 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "(Ex 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "+1 to +139"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "(Ex 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "+373 to +779"

Phrase: ")"

Phrase: "of PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "represented by the respective black boxes."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0005680:Black [Population Group]
   753   C0027567:Black [Population Group]
   753   C0085756:Black [Population Group]
   753   C0179400:boxes [Manufactured Object]
   753   C0439541:Black [Qualitative Concept]
   753   C1638312:Boxes [Quantitative Concept]
   719 E C1533124:Box [Medical Device]
   719   C1882932:Represent [Activity]
Processing 00000000.tx.71: The position of the PSEN1 -22C>T promoter polymorphism is indicated by an arrow. 

Phrase: "The position of the PSEN1 -22C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0733755:Position [Spatial Concept]

Phrase: ">T promoter polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "indicated by an arrow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.72: Restriction enzyme recognition sites used for subcloning into the pGL3 basic vector are represented in bold. 

Phrase: "Restriction enzyme recognition sites"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C1882940:Restriction Enzyme Recognition Site [Nucleotide Sequence]
           Restriction Enzyme Site
           Restriction Site
   812   C0205145:Sites [Spatial Concept]
   812   C0524637:Recognition [Mental Process]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "used for subcloning"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "into the pGL3 basic vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "are"

Phrase: "represented in bold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1882932:Represent [Activity]
Processing 00000000.tx.73: The deletion constructs in the pGL3 basic vector are represented by horizontal lines. 

Phrase: "The deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "constructs in the pGL3 basic vector"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1527178:Basic [Functional Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1854336:PGL3 [Disease or Syndrome]
   753   C2827421:Construct [Classification]
   753   C3273620:PGL3 [Gene or Genome]

Phrase: "are"

Phrase: "represented by horizontal lines."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205126:Horizontal [Spatial Concept]
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]
   737   C1882932:Represent [Activity]
Processing 00000000.tx.74: Position of the 5'- and 3'-end of each construct is given based on the exon1A transcription initiations site P1 reported by Pastorcic and Das (14). 

Phrase: "Position of the 5'-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0733755:Position [Spatial Concept]

Phrase: "and"

Phrase: "3'-end of each construct"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "is"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "based on the exon1A transcription initiations site P1"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   789   C0949639:Transcription Initiation Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   754   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   744   C0040649:Transcription [Genetic Function]
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C2825164:Site [Spatial Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711   C0589507:Initiation [Mental Process]
   711   C1704686:Initiation [Functional Concept]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "reported by Pastorcic"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "Das (14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   861   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.75: Bars represent the promoter activity of each construct in N2a (black) and HEK293 (white) cells. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the promoter activity of each construct"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in N2a"

Phrase: "(black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "HEK293"

Phrase: "(white) cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0023516:White Cell [Cell]
   861   C0007457:White [Population Group]
   861   C0007634:Cells [Cell]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.76: Transcriptional activities are expressed as a percentage of the SV40 early promoter activity. 

Phrase: "Transcriptional activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "expressed as a percentage of the SV40 early promoter activity."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0038975:SV 40 [Virus]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205177:Activity [Functional Concept]
   739   C0439165:Percentage [Quantitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1279919:Early [Temporal Concept]
   739   C1549488:Percentage [Idea or Concept]
   739   C1561533:Percentage [Idea or Concept]
   739   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.77: Values are the meanSD of in duplo measurements of at least three transfection experiments of three independent DNA preparations each.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the meanSD of"

Phrase: "in duplo measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "of"

Phrase: "at least three transfection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "of three independent DNA preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "each."
Processing 00000000.tx.78: The relative changes in transcriptional activity between most PSEN1 promoter constructs were in general similar in both cell lines (Fig.2). 

Phrase: "The relative changes in transcriptional activity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0025320:The change [Physiologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "between most PSEN1 promoter constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "were in general similar"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205246:General [Spatial Concept]
   770   C1553889:General [Idea or Concept]
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in both cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.79: All promoter constructs with 3'-ends downstream of exon1B at +1413 or +1257 showed an activity below background levels. 

Phrase: "All promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "constructs with 3'-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2827421:Construct [Classification]

Phrase: "ends downstream of exon1B at +1413 or +1257"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0444930:End [Spatial Concept]
   744   C0522506:Downstream [Spatial Concept]
   744   C2746065:End [Temporal Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an activity below background levels."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0683317:activity levels [Finding]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.80: Further 3' deletion of sequences up to +849 increased activity 10-fold to a maximum of 50% of SV40 promoter activity in HEK293, and 80% in N2a cells. 

Phrase: "Further 3' deletion of sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0162773:Sequence Deletion [Cell or Molecular Dysfunction]
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "up to +849 increased activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0474395:increased activity [Finding]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "10-fold to a maximum of 50% of SV40 promoter activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0332462:Fold [Spatial Concept]
   738   C1880834:FOLD [Phenomenon or Process]

Phrase: "in HEK293,"

Phrase: "and"

Phrase: "80% in N2a cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.81: Another 2-fold increase resulted from deletion of the remaining intron 1B sequences from +849 to +752. 

Phrase: "Another 2-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "resulted from deletion of the remaining intron 1B"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0450345:1B [Intellectual Product]
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1527428:Remaining [Qualitative Concept]
   744   C1880274:Deletion [Activity]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "sequences from +849 to +752."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.82: Of all promoter constructs ending in exon 1B at +752, the -113/+752 fragment showed the highest activity. 

Phrase: "Of all promoter constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "ending in exon 1B at +752,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0444930:ending [Spatial Concept]
   753   C0450345:1B [Intellectual Product]
   753   C2746065:Ending [Temporal Concept]

Phrase: "the -113/+752 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the highest activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.83: Additional 5' deletion of this fragment to -33/+752 decreased the activity 5-fold suggesting the presence of a general transcriptional activator in the -113/-33 region. 

Phrase: "Additional 5' deletion of this fragment to -33/+752"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1880274:Deletion [Activity]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the activity 5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a general transcriptional activator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the -113/-33 region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.84: Further deletion of 5' sequences between -33 and -20 increased activity again 2-fold in HEK293 cells, while in N2a cells this deletion resulted in a more dramatic 5-fold increase, leading to a transcriptional activity comparable with the activity of the -113/+752 fragment. 

Phrase: "Further deletion of 5' sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0162773:Sequence Deletion [Cell or Molecular Dysfunction]
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "between -33"

Phrase: "and -"

Phrase: "20 increased activity again 2-fold in HEK293 cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332462:Fold [Spatial Concept]
   742   C1880834:FOLD [Phenomenon or Process]

Phrase: "while in N2a cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0750519:while [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "this deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "resulted in a more dramatic 5-fold increase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0332462:Fold [Spatial Concept]
   744   C0442805:Increase [Functional Concept]
   744   C1880834:FOLD [Phenomenon or Process]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "leading to a transcriptional activity"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0040649:Transcriptional [Genetic Function]
   760   C0205177:Activity [Functional Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1522538:Leading [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "comparable with the activity of the -113/+752 fragment."
Processing 00000000.tx.85: These data suggested the presence of a strong silencer in the -33/-20 region with a higher impact on expression in N2a cells than in HEK293 cells. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a strong silencer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the -33/-20 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "with a higher impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825598:IMPACT [Gene or Genome]

Phrase: "on expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "than"

Phrase: "in HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.86: However, upon further deletion of the 3' end, the -33/+80 fragment showed the highest activity detected for both cell lines in this study, while the activity of the -20/+80 fragment did not exceed background levels. 

Phrase: "However,"

Phrase: "upon further deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "of the 3' end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "the -33/+80 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the highest activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "detected for both cell lines"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C0442726:Detected [Finding]
   760   C1269647:Cell [Cell]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "while"

Phrase: "the activity of the -20/+80 fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exceed"

Phrase: "background levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0441889:Levels [Qualitative Concept]
   861   C1706907:Background [Conceptual Entity]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.87: In rat primary neurons the -33/+80 fragment exhibited at least 30-fold greater activity than the -20/+80 fragment (Fig.3). 

Phrase: "In rat primary neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "the -33/+80 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "exhibited at least 30-fold greater activity"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0205177:Activity [Functional Concept]
   748   C0332462:Fold [Spatial Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0443228:greater [Quantitative Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1704243:Greater [Quantitative Concept]
   748   C1880834:FOLD [Phenomenon or Process]
   714   C0015272:Exhibit [Intellectual Product]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "than the -20/+80 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.88: Therefore, it appeared that the -33/-20 region harbours an important regulatory element that is strongly dependent on downstream regulatory elements and which is particularly responsive in neurons. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the -33/-20 region harbours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0475311:Harbour [Manufactured Object]

Phrase: "an important regulatory element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   827   C1705248:Element [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "strongly dependent on downstream regulatory elements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "which"

Phrase: "is"

Phrase: "particularly responsive in neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205342:Responsive [Functional Concept]
Processing 00000000.tx.89: View larger version (17K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.90: Transcriptional activity of the PSEN1 -22C/T variants in transient transfection experiments. 

Phrase: "Transcriptional activity of the PSEN1 -22C/T variants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0459205:Type of activity [Intellectual Product]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "in transient transfection experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.91: Bars represent firefly/renilla luciferase ratios for the different constructs (relative luciferase activity, RLA). 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "firefly/renilla luciferase ratios for the different constructs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0456603:Ratios [Quantitative Concept]
   744   C1610540:*Ratios [Quantitative Concept]
   711 E C1547037:Ratio [Intellectual Product]

Phrase: "(relative luciferase activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.92: (A) For the rat primary neurons transcriptional activities are presented as the percentage of the activity of the -20/+80 construct. 

Phrase: "(A) For the rat primary neurons transcriptional activities"

Phrase: "are"

Phrase: "presented as the percentage of the activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0205177:Activity [Functional Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0449450:Presented [Idea or Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]
   714 E C0150312:Present [Quantitative Concept]

Phrase: "of the -20/+80 construct."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]
Processing 00000000.tx.93: (B) For N2A and HEK293 cells transcriptional activities are presented as the percentage of the activity of the wild-type construct (-22T, black bars). 

Phrase: "(B) For N2A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "HEK293 cells transcriptional activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "presented as the percentage of the activity of the wild-type construct"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   766   C0459205:Type of activity [Intellectual Product]
   753   C1883559:Wild Type [Organism Attribute]
   736   C0205177:Activity [Functional Concept]
   736   C0332307:Type [Qualitative Concept]
   736   C0439165:Percentage [Quantitative Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C0445392:Wild [Intellectual Product]
   736   C0449450:Presented [Idea or Concept]
   736   C1547052:*Type [Quantitative Concept]
   736   C1549488:Percentage [Idea or Concept]
   736   C1561533:Percentage [Idea or Concept]
   736   C1561536:*Activity [Idea or Concept]
   736   C2827421:Construct [Classification]
   703 E C0150312:Present [Quantitative Concept]

Phrase: "(-22T,"

Phrase: "black bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: Values are the meanSD of in duplo measurements of at least three transfection experiments of three independent DNA preparations each.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the meanSD of"

Phrase: "in duplo measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "of"

Phrase: "at least three transfection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "of three independent DNA preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "each."
Processing 00000000.tx.95: 5' deletion of the major exon 1A TISs (+43/+849, +43/+752) did not completely abolish transcriptional activity, but resulted in a residual activity of about one-third of the activity of the respective exon 1A containing fragments (-20/+849 and -20/+752) in both cell types. 

Phrase: "5' deletion of the major exon 1A TISs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "(+43/+849,"

Phrase: "+43/+752"

Phrase: ")"

Phrase: "did"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "abolish"

Phrase: "transcriptional activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "resulted in a residual activity of about one-third of the activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   736   C0205177:Activity [Functional Concept]
   736   C0205437:Third [Quantitative Concept]
   736   C0205447:One [Quantitative Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1561536:*Activity [Idea or Concept]
   736   C1609982:Residual [Qualitative Concept]
   703   C1274040:Result [Functional Concept]
   703   C1546471:Result [Idea or Concept]
   703   C2825142:Result [Finding]

Phrase: "of the respective exon 1A containing fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "(-20/+849"

Phrase: "and -"

Phrase: "20/+752"

Phrase: ")"

Phrase: "in both cell types."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.96: Further deletion of the start of exon 1B (+536/+849, +536/+752) caused transcriptional activity to drop again to background levels. 

Phrase: "Further deletion of the start of exon 1B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "(+536/+849,"

Phrase: "+536/+752"

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "transcriptional activity to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "drop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1321095:Drop [Quantitative Concept]
  1000   C1705648:Drop [Activity]
  1000   C2347093:Drop [Quantitative Concept]
  1000   C2348338:Drop [Quantitative Concept]

Phrase: "again to background levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C1706907:Background [Conceptual Entity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.97: Transcriptional effect of PSEN1 -22C>T polymorphism We introduced the T-allele of -22C>T in the -292/+1257 fragment. 

Phrase: "Transcriptional effect of PSEN1 -22C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: ">T polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "We"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "the T-allele of -22C"

Phrase: ">T in the -292/+1257 fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.98: In transiently transfected HEK293 cells no significant differences in expression level were detected between -22T and -22C promoter constructs, whereas in N2a cells a 2-fold decrease was observed for -22C (Fig.3). 

Phrase: "In transiently transfected HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2936239:HEK293 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "no significant differences in expression level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "detected between -22T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "22C promoter constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "whereas in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "a 2-fold decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392756:Decrease [Qualitative Concept]
   827   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed for -22C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.99: We also introduced the -22T allele in the -33/+849 fragment. 

Phrase: "We also"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "the -22T allele in the -33/+849 fragment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.100: The transcriptional activity of -33/+849T was comparable with that of -20/+849 lacking the -22 position, while a 2-fold reduction in activity was detected for the C-allele in transiently transfected N2a and HEK293 cells (Fig.3). 

Phrase: "The transcriptional activity of -33/+849T"

Phrase: "was"

Phrase: "comparable with that of -20/+849"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the -22 position,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "while"

Phrase: "a 2-fold reduction in activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2267000:Reduction Activity [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected for the C-allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in transiently transfected N2a"

Phrase: "and"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.101: MatInspector v2.2 (19) indicated the presence of a high affinity binding site for NF-1, a member of an emerging family of DNA binding proteins, some being involved in neuron-specific regulation of transcription (20). 

Phrase: "MatInspector v2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0457423:V2 [Finding]
   827   C0507237:V2 [Body Part, Organ, or Organ Component]
   827   C1421140:V2 [Gene or Genome]

Phrase: "(19"

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the presence of a high affinity binding site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for NF-1,"

Phrase: "a member of an emerging family of DNA binding proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0086282:Family member [Family Group]
   757   C1611821:Family Member [Intellectual Product]
   739   C0680022:member [Population Group]
   739   C2698041:Member [Professional or Occupational Group]

Phrase: "some"

Phrase: "being"

Phrase: "involved in neuron-specific regulation of transcription"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C1158770:Transcription Regulation [Genetic Function]
   748   C0027882:Neuron [Cell]
   748   C0040649:Transcription [Genetic Function]
   748   C0205369:Specific [Qualitative Concept]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1552740:specific [Intellectual Product]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.102: Electrophoretic mobility shift assays We examined whether -22C>T affected the specific recognition of the PSEN1 promoter by nuclear factors using electrophoretic mobility shift assays (EMSA). 

Phrase: "Electrophoretic mobility shift assays"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   966   C0949632:Electrophoretic Mobility Shift Assay [Laboratory Procedure]
           Mobility Shift Assays
   812   C0333051:Shift [Functional Concept]
   812   C0425245:Mobility [Finding]
   812   C0449580:Mobility [Qualitative Concept]
   812   C2347509:Shift [Phenomenon or Process]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]
   741   C0013855:Electrophoreses [Laboratory Procedure]
   741 E C0231435:Mobile [Functional Concept]
   741 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether -"

Phrase: "22C"

Phrase: ">T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the specific recognition of the PSEN1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0524637:Recognition [Mental Process]

Phrase: "by nuclear factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521447:Nuclear [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "electrophoretic mobility shift assays (EMSA)."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   966   C0949632:Electrophoretic Mobility Shift Assay [Laboratory Procedure]
           Mobility Shift Assays
   812   C0333051:Shift [Functional Concept]
   812   C0425245:Mobility [Finding]
   812   C0449580:Mobility [Qualitative Concept]
   812   C2347509:Shift [Phenomenon or Process]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]
   741   C0013855:Electrophoreses [Laboratory Procedure]
   741 E C0231435:Mobile [Functional Concept]
   741 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.103: We started with -26/+1 double-stranded oligonucleotide probes containing either the C- or the T-allele. 

Phrase: "We"

Phrase: "started with -26/+1 double-stranded oligonucleotide probes"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   770   C0028952:Oligonucleotide Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   750   C0441087:Double probe [Medical Device]
   744   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0182400:Probes [Medical Device]
   744   C0205173:Double [Functional Concept]
   744   C1272689:Started [Qualitative Concept]
   744   C1705764:Double [Activity]
   744   C1705765:Double [Qualitative Concept]
   735   C1979882:Double strand [Qualitative Concept]
   711 E C0439659:Start [Temporal Concept]
   711 E C1704681:Probe [Gene or Genome]
   711 E C2347609:Probe [Chemical Viewed Functionally]
   711 E C3536729:Probe [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either"

Phrase: "the C-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "the T-allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.104: Both HEK293 and human neuroblastoma (SHSY-5Y) nuclear extracts contained nuclear proteins binding specifically to this region of the PSEN1 promoter resulting in the formation of one major complex. 

Phrase: "Both HEK293"

Phrase: "and"

Phrase: "human neuroblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027819:Neuroblastoma [Neoplastic Process]
   861   C0700095:neuroblastoma [Neoplastic Process]
   861   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(SHSY-5Y"

Phrase: ")"

Phrase: "nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "nuclear proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028589:Nuclear Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "specifically to this region of the PSEN1 promoter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   762   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0017446:Region [Geographic Area]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205147:Region [Spatial Concept]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "resulting in the formation of one major complex."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0332294:Resulting in [Functional Concept]
   744   C0205164:Major [Qualitative Concept]
   744   C0205447:One [Quantitative Concept]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C0678226:resulting [Functional Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]
Processing 00000000.tx.105: Competition with 1040-fold excess of unlabeled -26/+1 C or T probes resulted in complete inhibition of complex formation (Fig.4). 

Phrase: "Competition with 1040-fold excess of unlabeled -26/+1 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0679932:competition [Social Behavior]

Phrase: "or"

Phrase: "T probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "resulted in complete inhibition of complex formation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0205197:Complete [Qualitative Concept]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C0725685:COMPLEAT [Food]
   748   C1522492:Formation [Functional Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C3463820:Inhibition [Activity]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.106: However, no significant differences in complex mobility or binding affinity were detected between -26/+1C and -26/+1T. 

Phrase: "However,"

Phrase: "no significant differences in complex mobility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "binding affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "detected between -26/+1C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "26/+1T."
Processing 00000000.tx.107: Also, the phosphorylation status of the proteins in the nuclear extract had no influence on binding (Fig.4). 

Phrase: "Also,"

Phrase: "the phosphorylation status of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]

Phrase: "in the nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   861   C2828366:Extract [Substance]

Phrase: "had"

Phrase: "no influence on binding"

Phrase: "(Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.108: Competition with an Ets1/2 consensus probe also inhibited binding of nuclear factors to the PSEN1 -26/+1 probe, suggesting that the -22C>T polymorphism may effect the binding of ETS proteins to its previously reported binding site at position -12 (14). 

Phrase: "Competition with an Ets1/2 consensus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679932:competition [Social Behavior]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "also"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "binding of nuclear factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243122:binding [Functional Concept]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "to the PSEN1 -26/+1 probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0182400:Probe [Medical Device]
   804   C1704681:Probe [Gene or Genome]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the -22C"

Phrase: ">T polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "the binding of ETS proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C0033618:Protein Binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to its previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "binding site at position -12"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005456:Binding Site [Receptor]
   806   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.109: However, pre-incubation with -Ets1/2 or -Elk1 antibodies did not result in a super shift of the complexes (data not shown). 

Phrase: "However,"

Phrase: "pre-incubation with -Ets1/2 or -Elk1 antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332152:Pre [Temporal Concept]
   744   C0740175:Pre [Qualitative Concept]
   744   C2257086:PRE [Genetic Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in a super shift of the complexes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0333051:Shift [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   744   C2347509:Shift [Phenomenon or Process]
   744   C2825142:Result [Finding]
   711 E C0439855:Complex [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.110: Even when we extended the region of investigation into the 5' direction, using a probe spanning the -43/-6 region, we could not detect any allele-specific differences. 

Phrase: "Even"

Phrase: "when"

Phrase: "we"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "the region of investigation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "into the 5' direction,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0449738:Direction [Spatial Concept]
   761 E C1707761:Directionality [Functional Concept]
   761 E C3274524:Directionality [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the -43/-6 region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any allele-specific differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.111: View larger version (94K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(94K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.112: EMSA analysis of allele-specific effect of the -22C>T variation on the interaction of nuclear protein complexes extracted from HEK293 and SHSY-5Y cells with the (-26/+1) region. 

Phrase: "EMSA analysis of allele-specific effect of the -22C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1524024:analysis [Functional Concept]

Phrase: ">T variation on the interaction of nuclear protein complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:Variation [Qualitative Concept]

Phrase: "extracted from HEK293"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "SHSY-5Y cells with the (-26/+1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.113: DIG-labelled double-stranded probes (50fmol) were incubated with 10g nuclear extract from HEK293 and SH-SY5Y cells, respectively. 

Phrase: "DIG-labelled double-stranded probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   836   C0441087:Double probe [Medical Device]
   804   C0182400:Probes [Medical Device]
   771 E C1704681:Probe [Gene or Genome]
   771 E C2347609:Probe [Chemical Viewed Functionally]
   771 E C3536729:Probe [Manufactured Object]

Phrase: "(50fmol"

Phrase: ")"

Phrase: "were"

Phrase: "incubated with 10g nuclear extract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1518434:Nuclear Extract [Biomedical or Dental Material]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C2828366:Extract [Substance]

Phrase: "from HEK293"

Phrase: "and"

Phrase: "SH-SY5Y cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.114: PI, presence of phosphatase inhibitors 1 and 2 (Sigma). 

Phrase: "PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0429863:PI [Clinical Attribute]
  1000   C3537219:PI [Gene or Genome]
  1000   C3539772:PI [Intellectual Product]

Phrase: "presence of phosphatase inhibitors 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: Lanes 1, 36 and 1114 include the -22C risk allele. 

Phrase: "Lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "36"

Phrase: "and"

Phrase: "1114"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the -22C risk allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.116: Lanes 2, 710 and 1518 include the wild type -22T allele. 

Phrase: "Lanes 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "710"

Phrase: "and"

Phrase: "1518"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the wild type -22T allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.117: In competition experiments, 20-fold excess of unlabeled probe was added prior to the addition of the labelled probe.   

Phrase: "In competition experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "20-fold excess of unlabeled probe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1979886:Excess [Qualitative Concept]

Phrase: "was"

Phrase: "added prior to the addition of the labelled probe."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C0332152:Prior to [Temporal Concept]
           Prior
   742   C0182400:Probe [Medical Device]
   742   C1524062:Added [Functional Concept]
   742   C1704681:Probe [Gene or Genome]
   742   C1883712:Addition [Functional Concept]
       E   Add
   742   C2347609:Probe [Chemical Viewed Functionally]
   742   C2826257:PRIOR [Event]
   742   C3536729:Probe [Manufactured Object]
   708   C0181496:Label [Manufactured Object]
   708   C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.118: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Polymorphic variability within a gene promoter can effect gene expression and has previously been associated with age-related neurodegeneration (16,18,2124). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Polymorphic variability within a gene promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827666:Variability [Conceptual Entity]

Phrase: "can"

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "associated with age-related neurodegeneration"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0001779:Age [Organism Attribute]
   760   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(16,"

Phrase: "18,"

Phrase: "2124"

Phrase: ")."
Processing 00000000.tx.119: In this study we set out to analyse the PSEN1 promoter region in more detail with respect to the AD-associated -22C>T variation. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "analyse"

Phrase: "the PSEN1 promoter region in more detail"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017446:Region [Geographic Area]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205147:Region [Spatial Concept]

Phrase: "with respect to the AD-"

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "22C"

Phrase: ">T variation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.120: First we showed that both alternatively initiated exon 1A and 1B transcripts are present in different tissues and cell lines, although the exon 1B transcripts are at significant lower levels. 

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both alternatively initiated exon 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450344:1A [Intellectual Product]
   812   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "1B transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "present in different tissues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "although"

Phrase: "the exon 1B transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are at significant lower levels."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   762   C0814896:levels significance [Research Activity]
   760   C0237881:significant [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C1551058:Are [Quantitative Concept]
   760   C2003888:Lower [Activity]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.121: None of the transcripts contained both exon 1A and exon 1B. 

Phrase: "None of the transcripts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   770   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "both exon 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "exon 1B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]
Processing 00000000.tx.122: RLM-RACE analysis of the PSEN1 exon 1A transcripts revealed the presence of multiple TISs and provided evidence that the real start site of PSEN1 exon 1A is located 11bp upstream of P1. 

Phrase: "RLM-RACE analysis of the PSEN1 exon 1A transcripts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of multiple TISs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "provided evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the real start site of PSEN1 exon 1A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C2945843:Site of [Qualitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C0439659:Start [Temporal Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located"

Phrase: "11bp upstream of P1."
Processing 00000000.tx.123: Together our data indicated that the initiation of transcription and splicing of the 5' UTR exons of PSEN1 is complex and that its effect on transcription efficiency warrants further investigation. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the initiation of transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   770   C0589507:Initiation [Mental Process]
   770   C1704686:Initiation [Functional Concept]

Phrase: "and"

Phrase: "splicing of the 5' UTR exons of PSEN1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035687:Splicing [Genetic Function]
   742   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "that"

Phrase: "its effect on transcription efficiency warrants further investigation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.124: Next we constructed an extended deletion panel of the PSEN1 upstream regulatory region to allow for identification of sequence determinants required for the PSEN1 transcriptional activity. 

Phrase: "Next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "an extended deletion panel of the PSEN1 upstream regulatory region to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0441833:Panel [Idea or Concept]
   736   C1999270:Panel [Intellectual Product]
   736   C3537156:Panel [Manufactured Object]

Phrase: "allow for identification of sequence determinants"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0020792:Identification [Mental Process]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0205396:Identification [Qualitative Concept]
   753   C0683607:allow [Social Behavior]
   753   C1519249:Sequence [Functional Concept]
   719   C1521761:Determinant [Functional Concept]

Phrase: "required for the PSEN1 transcriptional activity."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   748   C0040649:Transcriptional [Genetic Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C1514873:Required [Functional Concept]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.125: One interesting result emerging from the 5' deletion analyses is the observation that transcription is not completely abolished when deleting the major exon 1A TISs. 

Phrase: "One interesting result emerging from the 5' deletion analyses"

Phrase: "is"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "abolished"

Phrase: "when"

Phrase: "deleting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880274:Delete [Activity]

Phrase: "the major exon 1A TISs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0040300:Tiss [Tissue]
   812   C0475413:Tis [Finding]
   812   C0556987:TIS [Temporal Concept]
Processing 00000000.tx.126: The residual activity can be due to transcription from the more downstream located minor TISs (15). 

Phrase: "The residual activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "be due to transcription"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0040649:Transcription [Genetic Function]
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]

Phrase: "from the more downstream located minor TISs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0040300:Tiss [Tissue]
   804   C0475413:Tis [Finding]
   804   C0556987:TIS [Temporal Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.127: Another, more likely, scenario is that transcription initiating from exon 1B is driven by promoter elements located downstream of the exon 1A TISs. 

Phrase: "Another,"

Phrase: "more likely,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683579:scenario [Functional Concept]

Phrase: "is"

Phrase: "that transcription initiating from exon 1B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "is"

Phrase: "driven by promoter elements"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0013879:Elements [Element, Ion, or Isotope]
   770   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0013126:Drive [Mental Process]
   737 E C1705248:Element [Conceptual Entity]

Phrase: "located downstream of the exon 1A TISs."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0040300:Tiss [Tissue]
   748   C0450344:1A [Intellectual Product]
   748   C0475413:Tis [Finding]
   748   C0522506:Downstream [Spatial Concept]
   748   C0556987:TIS [Temporal Concept]
   748   C1553633:1a [Medical Device]
Processing 00000000.tx.128: The latter hypothesis is favoured since transcriptional activity increases with deletion of all reported exon 1A TISs. 

Phrase: "The latter hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "favoured"

Phrase: "since transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "increases with deletion of all reported exon 1A TISs."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0040300:Tiss [Tissue]
   742   C0442805:Increase [Functional Concept]
   742   C0450344:1A [Intellectual Product]
   742   C0475413:Tis [Finding]
   742   C0556987:TIS [Temporal Concept]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1553633:1a [Medical Device]
   742   C1880274:Deletion [Activity]
   742   C3496591:Reported [Clinical Attribute]
   708 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.129: MatInspector v2.2 detected in the close proximity of exon 1B, the same combination of an Ets-1/2 binding site spanning the TIS and a number of GC-rich elements including an SP1 binding site, as was shown for exon 1A (14). 

Phrase: "MatInspector v2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0457423:V2 [Finding]
   827   C0507237:V2 [Body Part, Organ, or Organ Component]
   827   C1421140:V2 [Gene or Genome]

Phrase: "detected in the close proximity of exon 1B,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0442726:Detected [Finding]
   744   C0450345:1B [Intellectual Product]
   744   C0587267:Close [Functional Concept]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1514583:Proximity [Spatial Concept]

Phrase: "the same combination of an Ets-1/2 binding site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205195:Combination [Qualitative Concept]
   739   C1947911:Combination [Physical Object]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the TIS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0949639:Transcription Initiation Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   827   C0040649:Transcription [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0589507:Initiation [Mental Process]
   827   C1515974:Site [Body Location or Region]
   827   C1704686:Initiation [Functional Concept]
   827   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a number of GC-rich elements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an SP1 binding site,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "as"

Phrase: "was"

Phrase: "shown for exon 1A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0450344:1A [Intellectual Product]
   770   C1553633:1a [Medical Device]
   737   C1547282:Show [Intellectual Product]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.130: When removing the start of exon 1B, promoter activity dropped to background levels. 

Phrase: "When"

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the start of exon 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439659:Start [Temporal Concept]

Phrase: "promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "dropped to background levels."
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   770   C0441889:Levels [Qualitative Concept]
   770   C1705648:Dropped [Activity]
   770   C1706907:Background [Conceptual Entity]
   737 E C0456079:Level [Classification]
   737 E C1321095:Drop [Quantitative Concept]
   737 E C1547707:Level [Geographic Area]
   737 E C2347093:Drop [Quantitative Concept]
   737 E C2348338:Drop [Quantitative Concept]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.131: Our study is the first to demonstrate that the region downstream of the major exon 1A TISs contains functional promoter elements, most probably driving transcription from exon 1B both in neuronal and non-neuronal cells. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the region downstream of the major exon 1A TISs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1883633:Downstream Region [Nucleotide Sequence]
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "functional promoter elements,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "most probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0750492:Probably [Idea or Concept]

Phrase: "driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004379:Driving [Daily or Recreational Activity]
   966 E C0013126:Drive [Mental Process]

Phrase: "transcription from exon 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "both in neuronal"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0238767:Both [Spatial Concept]
   790   C0521390:Neuronal [Immunologic Factor]
   790   C1706086:Both [Qualitative Concept]
   718 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "non-neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.132: To study the effect of the promoter deletions on the alternative usage of the first exons and the activity of the exon 1B promoter in the presence of the exon 1A promoter, we propose to determine the occurrence of exon 1A and 1B transcripts in cells transfected with the PSEN1 promoter deletion constructs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effect of the promoter deletions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the alternative usage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457083:Usage [Functional Concept]

Phrase: "of the first exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the activity of the exon 1B promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the exon 1A promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "propose"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the occurrence of exon 1A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "and"

Phrase: "1B transcripts in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "transfected with the PSEN1 promoter deletion constructs."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PRESENILIN 1 [Gene or Genome]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]
   711   C2827421:Construct [Classification]
Processing 00000000.tx.133: Further we analysed the effect of the C- and T-alleles of the -22 polymorphism, located in the PSEN1 core promoter, on transcriptional activity by reporter gene expression in HEK293, N2a and rat primary neurons. 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "we"

Phrase: "analysed"

Phrase: "the effect of the C-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "T-alleles of the -22 polymorphism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]

Phrase: "located in the PSEN1 core promoter,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0444669:Core [Spatial Concept]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]

Phrase: "on transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "by reporter gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C0206414:Reporter Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HEK293,"

Phrase: "N2a"

Phrase: "and"

Phrase: "rat primary neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.134: The -22C>T variation, had an even larger effect on PSEN1 promoter activity than the previously reported EOAD mutation -254C>G (16). 

Phrase: "The -22C"

Phrase: ">T variation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "had"

Phrase: "an even larger effect on PSEN1 promoter activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "than the previously reported EOAD mutation -254C"

Phrase: ">G (16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.135: It also provided evidence that -22C>T modified transcriptional activity of the PSEN1 promoter in a cell-type specific manner. 

Phrase: "It also provided evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "that -22C"

Phrase: ">T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "transcriptional activity of the PSEN1 promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in a cell-type specific manner."
Processing 00000000.tx.136: In contrast to the human neuroblastoma cells (N2a), human embryonic kidney (HEK293) cells showed the 2-fold decrease in transcriptional activity for the risk (C) allele as compared with the wild-type (T) allele only for the -33/+849 promoter fragment. 

Phrase: "In contrast to the human neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(N2a"

Phrase: ")"

Phrase: ","

Phrase: "human embryonic kidney"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0086418:Human [Human]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(HEK293"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the 2-fold decrease in transcriptional activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "for the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "(C) allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "as"

Phrase: "compared with the wild-type (T) allele only"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0002085:Allele [Gene or Genome]
   748   C0205171:Only [Quantitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]
   748   C1707455:Compared [Activity]
   748   C1720467:Only [Intellectual Product]

Phrase: "for the -33/+849 promoter fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.137: Therefore, we suggest the presence of a cell-type-specific element in the sequence up or down stream of -33/+849 masking the transcriptional effect of -22C>T in HEK293 cells in vivo. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a cell-type-specific element"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "up"

Phrase: "or"

Phrase: "down stream of -33/+849"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0205104:Down [Spatial Concept]
   804   C0442540:Stream [Natural Phenomenon or Process]
   748 E C0423866:Lanugo [Body Part, Organ, or Organ Component]
   748 E C2626739:Lanugo [Eukaryote]

Phrase: "masking"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0150112:masking [Functional Concept]
   966 E C0024861:Mask [Medical Device]
   966 E C1538279:MASK [Gene or Genome]
   966 E C1845191:MASK [Gene or Genome]

Phrase: "the transcriptional effect of -22C"

Phrase: ">T in HEK293 cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0449475:cells type [Intellectual Product]
   802 E C0007634:Cell Type [Cell]
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.138: This can be either a HEK293 cell-specific inhibitor or a neuron-restrictive silencer element (NRSE) (25,26). 

Phrase: "This"

Phrase: "can"

Phrase: "be"

Phrase: "either"

Phrase: "a HEK293 cell-specific inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "a neuron-restrictive silencer element (NRSE)"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C1136185:Silencer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0027882:Neuron [Cell]
   812   C1705248:Element [Conceptual Entity]
   741 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.139: Although we did not detect the 21bp NRSE consensus sequence in the human PSEN1 upstream region, we cannot rule out the presence of other elements with similar function. 

Phrase: "Although"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the 21bp NRSE consensus sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   818   C0079160:Consensus Sequence [Nucleotide Sequence]
   795   C0004793:Sequence [Nucleotide Sequence]
   795   C0162326:Sequence [Nucleotide Sequence]
   795   C0162327:Sequence [Nucleotide Sequence]
   795   C0376298:Consensus [Social Behavior]
   795   C1519249:Sequence [Functional Concept]
   724 E C1548958:Sequential [Idea or Concept]
   724 E C1705294:Sequential [Qualitative Concept]

Phrase: "in the human PSEN1 upstream region,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C1883644:Upstream Region [Nucleotide Sequence]
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   804   C0522505:Upstream [Spatial Concept]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]
   717   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the presence of other elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "with similar function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.140: Additionally, deletion analysis showed that, for constructs ending at positions +849 or +752, the 5' deletion of the -33/-20 region resulted in an at least 2-fold increase of promoter activity, comparable to the presence of the T allele, suggesting that the presence of the -22 C allele results in a negative regulation of transcription. 

Phrase: "Additionally,"

Phrase: "deletion analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "for constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "ending at positions +849 or +752,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444930:ending [Spatial Concept]
   753   C0733755:positions [Spatial Concept]
   753   C2746065:Ending [Temporal Concept]

Phrase: "the 5' deletion of the -33/-20 region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "resulted in an at least 2-fold increase of promoter activity,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   738   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205177:Activity [Functional Concept]
   738   C0332462:Fold [Spatial Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C0442805:Increase [Functional Concept]
   738   C1561536:*Activity [Idea or Concept]
   738   C1880834:FOLD [Phenomenon or Process]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "comparable to the presence of the T allele,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the presence of the -22 C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "results in a negative regulation of transcription."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C1158770:Transcription Regulation [Genetic Function]
   748   C0040649:Transcription [Genetic Function]
   748   C0205160:Negative [Qualitative Concept]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1274040:Result [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1513916:Negative [Finding]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.141: However, further deletion at the 3' end showed that the silencing effect of the -33/-20 region is completely abolished in the absence of downstream elements, especially in neuronal cells. 

Phrase: "However,"

Phrase: "further deletion at the 3' end"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the silencing effect of the -33/-20 region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished in the absence of downstream elements,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0013879:Elements [Element, Ion, or Isotope]
   748   C0332197:absence [Quantitative Concept]
   748   C0522506:Downstream [Spatial Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   714 E C1705248:Element [Conceptual Entity]

Phrase: "especially in neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.142: These data suggested that a strong negative regulator binds to the sequence surrounding position -22 with the highest affinity for the AD-associated C-allele and that this binding is strongly dependent on downstream promoter elements. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a strong negative regulator"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0182953:REGULATOR [Medical Device]
   827   C0205160:Negative [Qualitative Concept]
   827   C1513916:Negative [Finding]
   827   C1704734:Regulator [Medical Device]
   827   C1704735:Regulator [Conceptual Entity]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]

Phrase: "binds to the sequence surrounding position -22"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0733755:Position [Spatial Concept]
   748   C1145667:Bind [Activity]
   748   C1167622:bind [Molecular Function]
   748   C1282914:Surrounding [Spatial Concept]
   748   C1519249:Sequence [Functional Concept]

Phrase: "with the highest affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for the AD-associated C-allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "this binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "strongly dependent on downstream promoter elements."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.143: This might be either a real inhibitor or a weak activator competing for a binding site with a stronger activator. 

Phrase: "This"

Phrase: "might"

Phrase: "be"

Phrase: "either"

Phrase: "a real inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "a weak activator competing for a binding site"

Phrase: "with a stronger activator."
Processing 00000000.tx.144: In this view, it is interesting that -22C>T is located in the core promoter, which has been shown to contain a functional Ets-1 like element at position -12 (14). 

Phrase: "In this view,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "it"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "that -22C"

Phrase: ">T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "located in the core promoter,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0444669:Core [Spatial Concept]
   760   C1167518:core [Cell Component]
   760   C1706352:Core [Medical Device]
   760   C1882467:Core [Manufactured Object]
   760   C3274653:Core [Body Substance]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a functional Ets-1 like element"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0812201:ETS-1 [Gene or Genome]
   753   C0013879:Element [Element, Ion, or Isotope]
   753   C0205245:Functional [Functional Concept]
   753   C0542341:Functional [Functional Concept]
   753   C1705248:Element [Conceptual Entity]
   753   C2700217:Functional [Conceptual Entity]

Phrase: "at position -12"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.145: Although MatInspector v2.2 predicted the presence of multiple transcription factor binding sites, some of which have been described to be involved in neuron-specific regulation of transcription (20), so far, no functional elements have been mapped to this region of the PSEN1 promoter. 

Phrase: "Although"

Phrase: "MatInspector v2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0457423:V2 [Finding]
   827   C0507237:V2 [Body Part, Organ, or Organ Component]
   827   C1421140:V2 [Gene or Genome]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "the presence of multiple transcription factor binding sites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in neuron-specific regulation of transcription"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C1158770:Transcription Regulation [Genetic Function]
   748   C0027882:Neuron [Cell]
   748   C0040649:Transcription [Genetic Function]
   748   C0205369:Specific [Qualitative Concept]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1552740:specific [Intellectual Product]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "so"

Phrase: "far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "no functional elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "mapped to this region of the PSEN1 promoter."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418985:PRESENILIN 1 [Gene or Genome]
   762   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   745   C1424473:MAP-1 [Gene or Genome]
   742   C0017446:Region [Geographic Area]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205147:Region [Spatial Concept]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   708   C0024779:Map [Manufactured Object]
   708   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.146: However, DNaseI footprint analyses in human neuroblastoma cells revealed the presence of a large protected area from -82 to -21 on the top strand, and even a larger footprint on the bottom strand from +33 to -82 (14). 

Phrase: "However,"

Phrase: "DNaseI footprint analyses in human neuroblastoma cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of a large protected area"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "from -82 to -21"

Phrase: "on the top strand,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "even"

Phrase: "a larger footprint on the bottom strand"

Phrase: "from +33 to -82"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.147: The very large footprints probably result from the binding of several proteins. 

Phrase: "The very large footprints probably"

Phrase: "result from the binding of several proteins."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   774   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
Processing 00000000.tx.148: In contrast, in HepG2 cells, no detectable footprint could be observed between -40 and -20, again suggesting the presence of a cell-type-specific regulatory element. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in HepG2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "no detectable footprint"

Phrase: "could"

Phrase: "be"

Phrase: "observed between -40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439509:/40 [Temporal Concept]
   790   C1441672:Observed [Functional Concept]

Phrase: "and -"

Phrase: "20,"

Phrase: "again"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a cell-type-specific regulatory element."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.149: Although EMSA showed that nuclear proteins extracted from HEK293 and human neuroblastoma cells (SHSY-5Y) specifically recognized the PSEN1 promoter region covering the -22 position, no significant differences in complex mobility or binding affinity were detected between the risk C- and wild-type T-alleles. 

Phrase: "Although"

Phrase: "EMSA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   966   C0949632:Electrophoretic Mobility Shift Assay [Laboratory Procedure]
           Mobility Shift Assays
   812   C0333051:Shift [Functional Concept]
   812   C0425245:Mobility [Finding]
   812   C0449580:Mobility [Qualitative Concept]
   812   C2347509:Shift [Phenomenon or Process]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]
   741   C0013855:Electrophoreses [Laboratory Procedure]
   741 E C0231435:Mobile [Functional Concept]
   741 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that nuclear proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028589:Nuclear Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "extracted from HEK293"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "human neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(SHSY-5Y"

Phrase: ")"

Phrase: "specifically"

Phrase: "recognized"

Phrase: "the PSEN1 promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "the -22 position,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "no significant differences in complex mobility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "binding affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "detected between the risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035647:Risk [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "C-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "wild-type T-alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.150: Competition with an Ets1/2 consensus probe inhibited binding of nuclear factors to the PSEN1 -26/+1 probe suggesting the presence of a protein of the ETS family. 

Phrase: "Competition with an Ets1/2 consensus probe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679932:competition [Social Behavior]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "binding of nuclear factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243122:binding [Functional Concept]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "to the PSEN1 -26/+1 probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0182400:Probe [Medical Device]
   804   C1704681:Probe [Gene or Genome]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of a protein of the ETS family."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.151: However, pre-incubation with -Ets1/2 or -Elk1 antibodies did not result in a super shift of the complexes, suggesting that these proteins are either not accessible to antibody recognition or not present in the complex binding to this region under these conditions. 

Phrase: "However,"

Phrase: "pre-incubation with -Ets1/2 or -Elk1 antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332152:Pre [Temporal Concept]
   744   C0740175:Pre [Qualitative Concept]
   744   C2257086:PRE [Genetic Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in a super shift of the complexes,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0333051:Shift [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   744   C2347509:Shift [Phenomenon or Process]
   744   C2825142:Result [Finding]
   711 E C0439855:Complex [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "either"

Phrase: "not accessible to antibody recognition"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in the complex binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0150312:Present [Quantitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "to this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "under these conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.152: However, since downstream elements are important for promoter activity it is possible that the differential binding to the -33/-20 region can only be detected when these elements are included in the probes. 

Phrase: "However,"

Phrase: "since"

Phrase: "downstream elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "are"

Phrase: "important for promoter activity"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the differential binding to the -33/-20 region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "these elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]

Phrase: "are"

Phrase: "included in the probes."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0182400:Probes [Medical Device]
   770   C0332257:included [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C1704681:Probe [Gene or Genome]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C2700399:Include [Activity]
   737 E C3536729:Probe [Manufactured Object]
Processing 00000000.tx.153: However, the exact downstream sequences involved in this cooperative action have still to be identified and the analysis of long probes in the presence of crude nuclear extracts poses technical difficulties. 

Phrase: "However,"

Phrase: "the exact downstream sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "involved in this cooperative action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441472:Action [Functional Concept]
   760   C0679729:cooperative [Organization]
   760   C1314939:Involved [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "have"

Phrase: "still to"

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "the analysis of long probes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of crude nuclear extracts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1258023:Crude Extracts [Chemical]
   867   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   793   C2828366:Extract [Substance]

Phrase: "poses"

Phrase: "technical difficulties."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1299586:difficulties [Finding]
   777 E C0332218:Difficult [Qualitative Concept]
Processing 00000000.tx.154: In conclusion, we detected maximal PSEN1 promoter activity for the smallest fragment -33/+80 spanning all exon 1A TISs in both N2A and HEK293 cells and therefore delineated the PSEN1 core promoter to this region. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "maximal PSEN1 promoter activity for the smallest fragment -33/+80"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "all exon 1A TISs in both N2A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0040300:Tiss [Tissue]
   748   C0475413:Tis [Finding]
   748   C0556987:TIS [Temporal Concept]

Phrase: "and"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "delineated"

Phrase: "the PSEN1 core promoter to this region."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.155: Also, we provided evidence for transcription initiation from exon 1B driven by its own promoter and the presence of exon1B transcripts in different tissues. 

Phrase: "Also,"

Phrase: "we"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "evidence for transcription initiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "from exon 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "driven by its own promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0013126:Drive [Mental Process]

Phrase: "and"

Phrase: "the presence of exon1B transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in different tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.156: The previously reported -22C>T polymorphism, associated with AD, is located in the PSEN1 core promoter in the 13bp (-33/-20) fragment containing a strong negative regulatory element involved in cell-type-specific inhibition of PSEN1 transcription. 

Phrase: "The previously"

Phrase: "reported -"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "22C"

Phrase: ">T polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with AD,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "located in the PSEN1 core promoter"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1418985:PRESENILIN 1 [Gene or Genome]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0444669:Core [Spatial Concept]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C1167518:core [Cell Component]
   748   C1706352:Core [Medical Device]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]

Phrase: "in the 13bp"

Phrase: "(-33/-20"

Phrase: ")"

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a strong negative regulatory element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   812   C1705248:Element [Conceptual Entity]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell-type-specific inhibition of PSEN1 transcription."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
Processing 00000000.tx.157: We demonstrated a 2-fold neuron-specific decrease for the -22C allele associated with AD using reporter gene analysis. 

Phrase: "We"

Phrase: "demonstrated"

Phrase: "a 2-fold neuron-specific decrease for the -22C allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392756:Decrease [Qualitative Concept]
   739   C0547047:Decrease [Quantitative Concept]

Phrase: "associated with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "reporter gene analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0206414:Reporter Gene [Gene or Genome]
Processing 00000000.tx.158: Previously, it was shown that a 50% reduction of PSEN1 levels significantly increased A42 production (11). 

Phrase: "Previously,"

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a 50% reduction of PSEN1 levels significantly increased A42 production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0301630:Reduction [Natural Phenomenon or Process]
   738   C0392756:Reduction [Qualitative Concept]
   738   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.159: Since most AD patients are homozygous for -22C, the corresponding 50% decrease in promoter activity would have a major effect on PSEN1 expression levels, possibly leading to increased A42 production. 

Phrase: "Since"

Phrase: "most AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "are"

Phrase: "homozygous for -22C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0019904:Homozygous [Organism Attribute]

Phrase: "the corresponding 50% decrease in promoter activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "would"

Phrase: "have"

Phrase: "a major effect on PSEN1 expression levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "leading to increased A42 production."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   781   C0861064:increased lead [Finding]
   760   C0033268:production [Occupational Activity]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1522538:Leading [Functional Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.160: In combination with other promoter variations, such as the -254C>G mutation, it might even lead to enhanced transcriptional effects. 

Phrase: "In combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with other promoter variations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variations [Qualitative Concept]

Phrase: "such as the -254C"

Phrase: ">G mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "it"

Phrase: "might"

Phrase: "even"

Phrase: "lead to enhanced transcriptional effects."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0040649:Transcriptional [Genetic Function]
   760   C1280500:effects [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2349975:Enhanced [Activity]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.161: Indeed, we have already demonstrated a neuron-specific 30% decrease (16) for this heterozygous EOAD-related mutation. 

Phrase: "Indeed,"

Phrase: "we"

Phrase: "have"

Phrase: "already"

Phrase: "demonstrated"

Phrase: "a neuron-specific 30% decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0392756:Decrease [Qualitative Concept]
   812   C0547047:Decrease [Quantitative Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "for this heterozygous EOAD-related mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.162: Together, our studies suggested an important role for variability in regulatory elements in the genetic predisposition for developing AD. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an important role for variability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "in the genetic predisposition"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
  1000   C0314657:Genetic Predisposition [Organism Attribute]
   861   C0012655:Predisposition [Clinical Attribute]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0220898:Predisposition [Organism Attribute]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   789 E C0231203:Predisposed [Functional Concept]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "for developing AD."
Processing 00000000.tx.163: Further characterization of the factors involved, and their mechanism of action, will no doubt contribute to the unravelling of AD pathology.  

Phrase: "Further characterization of the factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "their mechanism of action,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C0031327:mechanism of action [Physiologic Function]
   909   C1524059:mechanism of action [Functional Concept]
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "will"

Phrase: "no doubt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870444:doubt [Mental Process]
   928 E C0750558:Doubtful [Conceptual Entity]

Phrase: "contribute to the unravelling of AD pathology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0677042:pathology [Pathologic Function]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.164: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  RNA isolation, RTPCR and 5'RACE Total RNA from SH-SY5Y and HEK 293 cells was isolated using the SV Total RNA Isolation System (Promega, Madison, WI, USA). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "RNA isolation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "RTPCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "RACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034510:Race [Population Group]
  1000   C1706779:RACE [Gene or Genome]

Phrase: "Total RNA from SH-SY5Y"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "HEK 293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SV Total RNA Isolation System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Madison,"

Phrase: "WI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.165: Poly(A) RNA from human lymphoblasts was isolated using the Poly(A) Pure Kit (Ambion, Austin, USA). 

Phrase: "Poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "RNA from human lymphoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "Pure Kit (Ambion,"

Phrase: "Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.166: Human brain, testicle, liver and colon poly(A) RNA were purchased from Ambion. 

Phrase: "Human brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "testicle,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testicle [Body Part, Organ, or Organ Component]
  1000   C1284096:Testicle [Body Part, Organ, or Organ Component]
   928 E C0205070:Testicular [Spatial Concept]
   888 E C0021358:Testes [Body Part, Organ, or Organ Component]
   888 E C1278981:Testis [Body Part, Organ, or Organ Component]

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "colon poly(A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   827   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0747726:POLY [Conceptual Entity]

Phrase: ")"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "purchased from Ambion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.167: First-strand cDNA was generated from 100ng poly(A) RNA or 5g total RNA using random hexamers and oligo dT primers and the Superscript first strand synthesis system (Life Technologies, Paisley, UK) according to the manufacturer's protocol. 

Phrase: "First-strand cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "generated from 100ng poly(A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0032400:Poly A [Nucleic Acid, Nucleoside, or Nucleotide]
           poly
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0747726:POLY [Conceptual Entity]
   760   C3146294:Generated [Activity]

Phrase: ")"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "5g total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "random hexamers"

Phrase: "and"

Phrase: "oligo dT primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0069417:oligo (dT) [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the Superscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825228:Superscript [Intellectual Product]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "synthesis system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Paisley,"

Phrase: "UK"

Phrase: ")"

Phrase: "according to the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.168: Exon 1A transcripts were PCR amplified using primers 5'-tcacatcggaaacaaaacagc-3' (exon 1A) and 5'-acgtacagtattgctcaggtggtt-3' (exon 3) and exon 1B using primers 5'-ggagtggagtaggagaaagaggaa-3' (exon 1B) and 5'-acgtacagtattgctcaggtggtt-3' (exon 3) using standard PCR conditions and increasing amounts of HotGoldstar DNA polymerase (Eurogentec, Seraing, Belgium). 

Phrase: "Exon 1A transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 5'-tcacatcggaaacaaaacagc-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(exon 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "5'-acgtacagtattgctcaggtggtt-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(exon 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "and"

Phrase: "exon 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 5'-ggagtggagtaggagaaagaggaa-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(exon 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "5'-acgtacagtattgctcaggtggtt-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(exon 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard PCR conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "increasing amounts of HotGoldstar DNA polymerase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "(Eurogentec,"

Phrase: "Seraing,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")."
Processing 00000000.tx.169: 5' RLM-RACE was performed on 250ng mRNA using random hexamers and the GeneRacer Kit (Life Technologies) following the manufacturer's protocol. 

Phrase: "5' RLM-RACE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034510:Race [Population Group]
   827   C1706779:RACE [Gene or Genome]

Phrase: "was"

Phrase: "performed on 250ng mRNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "random hexamers"

Phrase: "and"

Phrase: "the GeneRacer Kit (Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.170: The 5' cDNA ends were amplified using the GeneRacer 5' Primer in combination with primer 5'-gtaggacaacggtgcaggtaactct-3' located in PSEN1 exon 3. 

Phrase: "The 5' cDNA ends"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0444930:ends [Spatial Concept]
   793 E C2746065:End [Temporal Concept]
   755 E C0205088:Terminal [Temporal Concept]
   755 E C1705314:Terminal [Manufactured Object]
   755 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GeneRacer 5' Primer in combination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with primer 5'-gtaggacaacggtgcaggtaactct-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "located in PSEN1 exon 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PRESENILIN 1 [Gene or Genome]
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.171: PCR products were cloned using the TOPO TA cloning for sequencing kit (Life Technologies) and sequenced using the Big Dye Terminator sequencing kit (ABI, Foster City, CA, USA). 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TOPO TA cloning for sequencing kit (Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0009015:Cloning [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Big Dye Terminator sequencing kit (ABI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1328319:ABI [Clinical Attribute]

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.172: PSEN1 promoter luciferase reporter constructs Genomic DNA fragments spanning parts of the putative PSEN1 promoter were subcloned upstream of the firefly luciferase gene (Fig.2A). 

Phrase: "PSEN1 promoter luciferase reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0335038:Reporter [Professional or Occupational Group]
   804   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   804   C1705915:Reporter [Conceptual Entity]
   804   C1709908:Reporter [Group]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "spanning parts of the putative PSEN1 promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1292711:Part of [Spatial Concept]
   744   C0449719:parts [Spatial Concept]
   744   C1709471:PARTS [Quantitative Concept]

Phrase: "were"

Phrase: "subcloned upstream of the firefly luciferase gene"

Phrase: "(Fig.2A"

Phrase: ")."
Processing 00000000.tx.173: Different fragments of plasmid B22, containing exons 1A and 1B of PSEN1 and 6.5kb of upstream sequences (27,16), were subcloned into the promoterless pGL3-basic vector (Promega): the 4914bp BglII/BamHI fragment spanning nucleotides -3501/+1413, the 2447bp HindIII fragment spanning -1190/+1257, the 1743bp NheI/HindIII fragment spanning -486/+1257, the 1549bp KpnI/HindIII fragment spanning -292/+1257, the 1370bp SacI/HindIII fragment spanning -113/+1257 and the 632bp XhoI/HindIII fragment spanning +626/+1257 (numbering according to the major exon 1A TIS reported by Pastorcic and Das, (14). 

Phrase: "Different fragments of plasmid B22,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "exons 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "1B of PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "6.5kb of upstream sequences"

Phrase: "(27,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "subcloned into the promoterless pGL3-basic vector"

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ":"

Phrase: "the 4914bp BglII/BamHI fragment spanning nucleotides -3501/+1413,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0332255:fragment [Functional Concept]
   793   C1708096:Fragment [Qualitative Concept]
   760   C1711300:Span [Conceptual Entity]
   760   C2700613:Span [Quantitative Concept]

Phrase: "the 2447bp HindIII fragment spanning -1190/+1257,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]
   766   C1711300:Span [Conceptual Entity]
   766   C2700613:Span [Quantitative Concept]

Phrase: "the 1743bp NheI/HindIII fragment spanning -486/+1257,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0332255:fragment [Functional Concept]
   795   C1708096:Fragment [Qualitative Concept]
   762   C1711300:Span [Conceptual Entity]
   762   C2700613:Span [Quantitative Concept]

Phrase: "the 1549bp KpnI/HindIII fragment spanning -292/+1257,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0332255:fragment [Functional Concept]
   795   C1708096:Fragment [Qualitative Concept]
   762   C1711300:Span [Conceptual Entity]
   762   C2700613:Span [Quantitative Concept]

Phrase: "the 1370bp SacI/HindIII fragment spanning -113/+1257"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0332255:fragment [Functional Concept]
   795   C1519179:SACI [Health Care Related Organization]
   795   C1708096:Fragment [Qualitative Concept]
   795   C1854580:SACI [Gene or Genome]
   762   C1711300:Span [Conceptual Entity]
   762   C2700613:Span [Quantitative Concept]

Phrase: "and"

Phrase: "the 632bp XhoI/HindIII fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "+626/+1257"

Phrase: "(numbering according to the major exon 1A TIS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0449788:numbering [Quantitative Concept]
   706 E C0237753:*Number [Quantitative Concept]

Phrase: "reported by Pastorcic"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.174: Later this deletion panel was refined with PCR-based deletion clones (Fig.2A). 

Phrase: "Later"

Phrase: "this deletion panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "was"

Phrase: "refined with PCR-based deletion clones"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   753   C0009013:Clones [Cell]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1880274:Deletion [Activity]
   742   C0206123:Clonal Deletion [Organ or Tissue Function]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1522642:Clone [Tissue]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(Fig.2A"

Phrase: ")."
Processing 00000000.tx.175: Genomic fragments were obtained by PCR amplification using the proofreading Pfu polymerase (Promega) and primers designed to our published sequence of the human PSEN1 upstream region (AF205592) (16). 

Phrase: "Genomic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "obtained by PCR amplification"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C1301820:Obtained [Functional Concept]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]
   737 E C1706701:Obtain [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the proofreading Pfu polymerase (Promega)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0136227:Pfu polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "designed to our published sequence of the human PSEN1 upstream region"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   770   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1418985:PRESENILIN 1 [Gene or Genome]
   753   C1883644:Upstream Region [Nucleotide Sequence]
   736   C0004793:Sequence [Nucleotide Sequence]
   736   C0017446:Region [Geographic Area]
   736   C0034037:Published [Occupational Activity]
   736   C0086418:Human [Human]
   736   C0162326:Sequence [Nucleotide Sequence]
   736   C0162327:Sequence [Nucleotide Sequence]
   736   C0205147:Region [Spatial Concept]
   736   C0522505:Upstream [Spatial Concept]
   736   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   736   C1519249:Sequence [Functional Concept]
   736   C1704324:Published [Intellectual Product]
   703   C1707689:Design [Activity]
   703   C2983265:DESIGN [Intellectual Product]

Phrase: "(AF205592"

Phrase: ")"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.176: Primers were designed to incorporate restriction enzyme sites at the end of the amplified products to facilitate subcloning of the fragments in pGL3-basic. 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "incorporate"

Phrase: "restriction enzyme sites at the end of the amplified products to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   759   C1882940:Restriction Enzyme Site [Nucleotide Sequence]
           Restriction Site
   738   C0205145:Sites [Spatial Concept]
   737   C2945843:Site of [Qualitative Concept]
   704 E C1515974:Site [Body Location or Region]
   704 E C2825164:Site [Spatial Concept]

Phrase: "facilitate"

Phrase: "subcloning of the fragments"

Phrase: "in pGL3-basic."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1527178:Basic [Functional Concept]
   789 E C0920750:basicity [Quantitative Concept]
Processing 00000000.tx.177: The Quick-change in vitro mutagenesis kit (Stratagene, La Jolla, CA, USA) was used to introduce the T allele at position -22 in the 1549bp KpnI/HindIII fragment using primer 5'-gtgggccggccgccaacgaTgccagagccggaaatgacg-3' and its reverse complement. 

Phrase: "The Quick-change in vitro mutagenesis kit (Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "the T allele at position -22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "in the 1549bp KpnI/HindIII fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer 5'-gtgggccggccgccaacgaTgccagagccggaaatgacg-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "its reverse complement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.178: The upper primer designed to amplify the 882bp -33/+849 fragment spans position -22, the T allele was introduced in this fragment using an upper primer corresponding to the T allele. 

Phrase: "The upper primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "the 882bp -33/+849 fragment spans position -22,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   795   C0332255:fragment [Functional Concept]
   795   C0733755:Position [Spatial Concept]
   795   C1708096:Fragment [Qualitative Concept]
   762   C1711300:Span [Conceptual Entity]
   762   C2700613:Span [Quantitative Concept]
   724 E C0240795:POSITIONAL [Finding]

Phrase: "the T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "introduced in this fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332255:fragment [Functional Concept]
   770   C1708096:Fragment [Qualitative Concept]
   737   C1292748:introduce [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an upper primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "corresponding to the T allele."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.179: -22T clones were selected by HgaI digestion. 

Phrase: "-22T clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "selected by HgaI digestion."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0012238:Digestion [Organism Function]
   770   C2349986:Digestion [Research Activity]
   737   C1707391:Select [Activity]
   715 E C0443277:Peptic [Functional Concept]
Processing 00000000.tx.180: The integrity of all inserts was confirmed by sequence analysis using the Thermo SequenaseTM II Dye Terminator Cycle Sequencing Kit (Amersham) using vector- and PSEN1-specific primers designed for screening of the PSEN1 5' upstream region (16). 

Phrase: "The integrity of all inserts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed by sequence analysis"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0750484:Confirmed [Idea or Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1519249:Sequence [Functional Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Thermo SequenaseTM II Dye Terminator Cycle Sequencing Kit (Amersham"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "vector-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "PSEN1-specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "designed for screening of the PSEN1 5' upstream region"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C1883644:Upstream Region [Nucleotide Sequence]
   739   C0017446:Region [Geographic Area]
   739   C0205147:Region [Spatial Concept]
   739   C0220908:Screening [Health Care Activity]
   739   C0220909:screening [Functional Concept]
   739   C0522505:Upstream [Spatial Concept]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   739   C1698960:screening [Intellectual Product]
   739   C1710031:Screening [Diagnostic Procedure]
   739   C1710477:SCREENING [Research Activity]
   706   C1707689:Design [Activity]
   706   C2983265:DESIGN [Intellectual Product]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.181: Sequences were assembled using the Lasergene software (DNASTAR Inc., Madison, WI, USA). 

Phrase: "Sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "assembled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706853:Assemble [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Lasergene software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(DNASTAR Inc.,"

Phrase: "Madison,"

Phrase: "WI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.182: Eukaryotic cell culture and transient transfection Mouse Neuro2a neuroblastoma (28) and human SH-SY5Y neuroblastoma cells were propagated in a minimal essential medium with Earle's salt (Life Technologies), 10% foetal bovine serum (Life Technologies), 2mM L-glutamine (Life Technologies), 200IU/ml of penicillin, 200g/ml of streptomycin (Life Technologies) and 0.1mM nonessential amino acids (Life Technologies). 

Phrase: "Eukaryotic cell culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
   734   C0015161:Eukaryotic Cell [Cell]

Phrase: "and"

Phrase: "transient transfection Mouse Neuro2a neuroblastoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1524043:Mouse Neuroblastoma [Neoplastic Process]
   804   C0027819:Neuroblastoma [Neoplastic Process]
   804   C0700095:neuroblastoma [Neoplastic Process]
   804   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "human SH-SY5Y neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   897   C0427861:Human cells [Laboratory or Test Result]
   823   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "propagated in a minimal essential medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0205224:Essential [Qualitative Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0547040:Minimal [Qualitative Concept]
   753   C1524031:MINIMAL [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C2945599:Minimal [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]

Phrase: "with Earle's salt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0036140:Salt [Chemical Viewed Structurally]
   861   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0206136:Salt [Food,Inorganic Chemical]
   789 E C1537053:salty [Qualitative Concept]
   761 E C0678584:saltiness [Qualitative Concept]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "10% foetal bovine serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0229671:Serum [Body Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "2mM L-glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "200IU/ml of penicillin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "200g/ml of streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "and"

Phrase: "0.1mM nonessential amino acids"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.183: Human embryonic kidney cells (HEK293) were propagated in OptiMem (Life Technologies) with 10% fetal bovine serum, 200IU/ml of penicillin and 200g/ml of streptomycin. 

Phrase: "Human embryonic kidney cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(HEK293"

Phrase: ")"

Phrase: "were"

Phrase: "propagated in OptiMem"

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "with 10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "200IU/ml of penicillin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "200g/ml of streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.184: For transient transfection N2a and HEK293 cells were seeded in six-well tissue culture dishes, at 9x104 and 7x105 cells/well, respectively, and allowed to recover for 24h. 

Phrase: "For transient transfection N2a"

Phrase: "and"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in six-well tissue culture dishes,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   797   C0492792:DISH, TISSUE CULTURE [Medical Device]
   778   C0040284:Tissue culture [Laboratory Procedure]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0205170:Well [Qualitative Concept]
   748   C0205452:Six [Quantitative Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3146287:Well [Manufactured Object]
   714   C0020498:DISH [Disease or Syndrome]
   714   C0036563:Seed [Plant]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "at 9x104"

Phrase: "and"

Phrase: "7x105 cells/well,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2347578:Cells/well [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "respectively,"

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover for 24h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0456696:/24h [Temporal Concept]
   790   C0521108:recover [Qualitative Concept]
   790   C1442770:24H [Temporal Concept]
   790   C2004454:recover [Organism Function]
Processing 00000000.tx.185: Cells were co-transfected with 20ng of pRL-TK plasmid containing the herpes simplex virus thymidine kinase promoter upstream of the renilla luciferase gene (Promega) and 1g of either one of the PSEN1 promoter constructs or one of the control plasmids, using the Lipofectamine procedure (Life Technologies). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with 20ng of pRL-TK plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0220928:TK [Geographic Area]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the herpes simplex virus thymidine kinase promoter upstream of the renilla luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   749   C0314621:Promoter gene [Gene or Genome]
   735   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "1g of either one of the PSEN1 promoter constructs"

Phrase: "or"

Phrase: "one of the control plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Lipofectamine procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "(Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.186: Empty pGL3-basic vector was used as a negative control, pGL3-promoter plasmid containing the SV40 early promoter upstream of the firefly luciferase gene (Promega) as a positive control. 

Phrase: "Empty pGL3-basic vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "used as a negative control,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "pGL3-promoter plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the SV40 early promoter upstream of the firefly luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0314621:Promoter gene [Gene or Genome]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "as a positive control."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.187: Primary neuron culture and transient transfection Time-mated SpragueDawley dams (B&K, UK Ltd) were sacrificed by cervical dislocation. 

Phrase: "Primary neuron culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transient transfection Time-mated SpragueDawley dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2239937:DAMS [Gene or Genome]

Phrase: "(B&K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "UK Ltd)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1136140:LTD [Organ or Tissue Function]

Phrase: "were"

Phrase: "sacrificed by cervical dislocation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2983594:Cervical Dislocation [Research Activity]
   770   C0012691:Dislocation [Injury or Poisoning]
   770   C0027530:Cervical [Body Location or Region]
   770   C0205064:Cervical [Spatial Concept]
   737   C0681205:Sacrifice [Idea or Concept]
Processing 00000000.tx.188: The E18 fetuses were collected and placed in Ca2+Mg2+-free HBSS. 

Phrase: "The E18 fetuses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0015965:Fetuses [Embryonic Structure]
   861   C2708510:# Fetuses [Clinical Attribute]
   827 E C0242291:FETUS [Tissue]
   827 E C1305737:Fetus [Anatomical Structure]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "placed in Ca2+Mg2+-free HBSS."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0332296:free [Functional Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1417500:MG2 [Gene or Genome]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   719   C0442504:Place [Spatial Concept]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.189: The brains were removed and meningeal tissue dissected away. 

Phrase: "The brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "meningeal tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1281814:Meningeal tissue [Body Part, Organ, or Organ Component]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: "away."
Processing 00000000.tx.190: The cerebral hemispheres were isolated by dissection and transferred to a 15ml tube and washed three times with fresh HBSS. 

Phrase: "The cerebral hemispheres"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0228174:Cerebral Hemispheres [Body Part, Organ, or Organ Component]
  1000   C1707523:Cerebral Hemispheres [Tissue]
   966 E C0007783:Cerebral hemisphere [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated by dissection"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0012737:Dissection [Therapeutic or Preventive Procedure]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "transferred to a 15ml tube"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0175730:Tube [Medical Device]
   760   C0348011:transferred [Functional Concept]
   760   C1547937:Tube NOS [Intellectual Product]
   760   C1561954:tube [Conceptual Entity]
   760   C1704730:TUBE [Medical Device]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "washed three times with fresh HBSS."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.191: Ten millilitres of trypsin solution were then added to the tissue and incubated at 37C for 20min. 

Phrase: "Ten millilitres of trypsin solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439242:millilitre [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to the tissue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0040300:Tissue [Tissue]
   770   C1524062:Added [Functional Concept]
   770   C1547928:Tissue [Intellectual Product]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 20min."
Processing 00000000.tx.192: The tissue was then washed in B27 supplemented Neurobasal containing 10% FCS and DNAse 1 and then triturated with a fire polished pasture pipette. 

Phrase: "The tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed in B27"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1537935:B27 [Gene or Genome]
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "supplemented"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0242295:Supplement [Food]
   966   C1947943:Supplement [Intellectual Product]
   966   C2348609:Supplement [Functional Concept]

Phrase: "Neurobasal"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% FCS"

Phrase: "and"

Phrase: "DNAse 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "triturated with a fire polished pasture pipette."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0016141:Fire [Phenomenon or Process]
   748   C0182301:Pipette [Medical Device]
   748   C0220896:polished [Population Group]
   748   C0700614:Fire [Natural Phenomenon or Process]
   748   C0702194:Fire [Human-caused Phenomenon or Process]
   748   C1706407:Pipette [Medical Device]
   748   C1880775:FIRE [Event]
Processing 00000000.tx.193: Dissociated cells were diluted to 1x106cells/ml in Neurobasal medium +B27 and plated onto poly-D-lysine coated 24 well Falcon plates at 5x105/well for reporter gene assay. 

Phrase: "Dissociated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "diluted to 1x106cells/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439526:/mL [Quantitative Concept]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "in Neurobasal medium +B27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1537935:B27 [Gene or Genome]

Phrase: "and"

Phrase: "plated onto poly-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0747726:POLY [Conceptual Entity]
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "D-"

Phrase: "lysine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522408:Coated [Qualitative Concept]
   966 E C0453946:Coat [Manufactured Object]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "24 well Falcon plates at 5x105/well"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C1139930:plates [Medical Device]
   714 E C0005971:Plate [Medical Device]
   714 E C3537155:Plate [Manufactured Object]

Phrase: "for reporter gene assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0206414:Reporter Gene [Gene or Genome]
Processing 00000000.tx.194: Primary neurones were cultured for 7 days in Neurobasal+B27 supplement (Invitrogen) and were subsequently transfected with 200ng of each PSEN1-luciferae reporter construct plus 25ng of Renilla luciferase under a TK promoter (Promega) with 2l Lipofectamine 2000 in 300l of Optimem according to the manufacturers instructions (Invitrogen). 

Phrase: "Primary neurones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurone [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "cultured for 7 days"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0439228:days [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439505:/day [Temporal Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in Neurobasal+B27 supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242295:Supplement [Food]
   827   C1947943:Supplement [Intellectual Product]
   827   C2348609:Supplement [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "subsequently"

Phrase: "transfected with 200ng of each PSEN1-luciferae reporter construct"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PRESENILIN 1 [Gene or Genome]
   739   C0335038:Reporter [Professional or Occupational Group]
   739   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   739   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   739   C1705915:Reporter [Conceptual Entity]
   739   C1709908:Reporter [Group]
   739   C2827421:Construct [Classification]

Phrase: "plus 25ng"

Phrase: "of Renilla luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "under a TK promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "with 2l Lipofectamine 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1312445:lipofectamine 2000 [Organic Chemical]
   827   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "in 300l"

Phrase: "of Optimem"

Phrase: "according to the manufacturers instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.195: Luciferase activity Transfected cells were cultured for 48h, washed with 1ml phosphate-buffered saline (PBS, Life Technologies), and lysed with Passive lysis buffer (Promega). 

Phrase: "Luciferase activity Transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 48h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1442464:48H [Temporal Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "washed with 1ml phosphate-buffered saline"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C1548982:Washed [Idea or Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719 E C0441648:Wash [Activity]

Phrase: "(PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "lysed with Passive lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:Lysis [Pathologic Function]
           lysed
   760   C1536403:lysis [Cell Function]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.196: Firefly luciferase activities (LAF) and renilla luciferase activities (LAR) were measured sequentially using a Dual-Luciferase reporter assay system (Promega) and a model TD-20E Luminometer (Turner design). 

Phrase: "Firefly luciferase activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1324397:firefly luciferase activity [Molecular Function]
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(LAF)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021755:LAF [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "renilla luciferase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "(LAR)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419115:LAR [Gene or Genome]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "sequentially"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Dual-Luciferase reporter assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "a model TD-20E Luminometer"

Phrase: "(Turner design"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.197: To correct for transfection efficiency and DNA uptake, the relative luciferase activity (RLA) was calculated as RLA=LAF/LAR. 

Phrase: "To correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for transfection efficiency"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "and"

Phrase: "DNA uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "the relative luciferase activity (RLA)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "calculated as RLA"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1151115:luciferase activity [Molecular Function]
   760   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0080103:Relative [Family Group]
   760   C0205177:Activity [Functional Concept]
   760   C0205345:Relative [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1547039:*Relative [Quantitative Concept]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "=LAF/LAR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419115:LAR [Gene or Genome]
Processing 00000000.tx.198: To compare the RLAs between different cell lines, relative RLA was calculated as a percentage of the RLA of the SV40 promoter construct %RLA=(RLA/RLASV40)*100 or the wild-type construct %RLA=(RLAmt/RLAwt)*100. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the RLAs between different cell lines,"

Phrase: "relative RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1151115:luciferase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "calculated as a percentage of the RLA"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C1151115:luciferase activity [Molecular Function]
   742   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   742   C0080103:Relative [Family Group]
   742   C0205177:Activity [Functional Concept]
   742   C0205345:Relative [Qualitative Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0444686:Calculated [Functional Concept]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1547039:*Relative [Quantitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "of the SV40 promoter construct %RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1151115:luciferase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "="

Phrase: "(RLA/RLASV40"

Phrase: ")"

Phrase: "*100"

Phrase: "or"

Phrase: "the wild-type construct %RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1151115:luciferase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "="

Phrase: "(RLAmt/RLAwt"

Phrase: ")"

Phrase: "*100."
Processing 00000000.tx.199: Preparation of nuclear extracts HEK293 and SH-SY5Y cells were grown under normal growth conditions to a density of 0.51x106cells/ml. 

Phrase: "Preparation of nuclear extracts HEK293"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown under normal growth"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0018270:normal growth [Organism Function]
           'growth' NOS
   833   C0578019:Normal growth [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0220844:growth [Physiologic Function]
   770   C0439166:% normal [Quantitative Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2347086:% Normal [Quantitative Concept]
   770   C2911660:Growth [Activity]

Phrase: "conditions to a density of 0.51x106cells/ml."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0012634:condition [Disease or Syndrome]
   744   C0178587:density [Quantitative Concept]
   744   C0348080:Condition [Qualitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.200: Approximately 109 cells were harvested in PBS (Life Technologies), washed twice in PBS, homogenized to single cell suspension and pelleted by centrifugation at 950g at 4C for 15min. 

Phrase: "Approximately 109 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested in PBS (Life Technologies"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0039421:technologies [Occupation or Discipline]
   760   C0376558:Life [Idea or Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726   C1512335:Harvest [Health Care Activity]

Phrase: ")"

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "homogenized to single cell suspension"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0007634:Cell [Cell]
   760   C0037179:Single [Population Group]
   760   C0038960:Suspension [Biomedical or Dental Material]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1382107:Suspension [Substance]
   760   C1704653:Cell [Medical Device]
   760   C1705537:Suspension [Functional Concept]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "pelleted by centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "at 950g"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 15min."
Processing 00000000.tx.201: Nuclear extracts were prepared according to a modified Dignam et al. 

Phrase: "Nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared according to a modified Dignam et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0217843:ET-A [Amino Acid, Peptide, or Protein,Receptor]
   744   C0392747:Modified [Functional Concept]
   744   C0680240:according [Social Behavior]
   711   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.202: (29) procedure. 

Phrase: "(29"

Phrase: ")"

Phrase: "procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.203: Cells were resuspended in five packed cell volumes (pcv) of hypotonic buffer H containing 20mM Hepes pH 7.9, 1.5mM MgCl2, 10mM KCl and freshly added 1mM DTT, 1mM PMSF, 1xprotease inhibitor Complete (Roche, Basel, Switzerland) and different phosphatase inhibitor cocktails (Sigma St. Louis, USA). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in five packed cell volumes (pcv)"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   799   C0018935:Packed cell volume [Laboratory Procedure]
   799   C1318015:Packed cell volume [Laboratory or Test Result]
   790   C0596292:Volumes, Cell [Organism Attribute,Quantitative Concept]
   773   C2700192:Five Pack [Quantitative Concept]
   753   C0007634:Cell [Cell]
   753   C0184967:Packed [Therapeutic or Preventive Procedure]
   753   C0205451:Five [Quantitative Concept]
   753   C0449468:volumes [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1690016:% volume [Qualitative Concept]
   719 E C1705102:Volume [Intellectual Product]
   719 E C1968515:Pack [Medical Device]
   719 E C2700258:Volume [Laboratory Procedure]
   719 E C2825051:Pack [Drug Delivery Device]
   719 E C2828395:Pack [Activity]

Phrase: "of hypotonic buffer H containing 20mM Hepes pH 7.9,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   866   C0067456:H-9 [Organic Chemical,Pharmacologic Substance]
   854   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   807   C1882074:pH 7 [Qualitative Concept]
   791   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   791   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   791   C0020283:[pH] [Quantitative Concept]
   791   C0033727:H+ [Element, Ion, or Isotope]
   791   C0241938:Hypotonic [Pathologic Function]
   791   C0332256:Containing [Functional Concept]
   791   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0441932:H+ [Classification]
   791   C0450407:ph+ [Finding]
   791   C0450408:ph++ [Finding]
   791   C0450409:ph+++ [Finding]
   791   C0564385:/h [Quantitative Concept]
   791   C2700400:Containing [Activity]

Phrase: "1.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10mM KCl"

Phrase: "and"

Phrase: "freshly added 1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM PMSF,"

Phrase: "1xprotease inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "Complete"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205197:Complete [Qualitative Concept]
  1000   C0725685:COMPLEAT [Food]
   928 E C0439812:Completeness [Qualitative Concept]

Phrase: "(Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "different phosphatase inhibitor cocktails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678420:cocktails [Food]

Phrase: "(Sigma St. Louis,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.204: After 15min of swelling on ice the cells were vortexed for 10s. 

Phrase: "After 15min"

Phrase: "of swelling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0013604:SWELLING [Pathologic Function]
  1000   C0038999:Swelling [Finding]
   907 E C1709317:Oncosis [Cell Function]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "vortexed for 10s."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439648:vortexed [Spatial Concept]
   790   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   790   C1552124:10s [Body Part, Organ, or Organ Component]
   756 E C2719416:Vortex [Pharmacologic Substance]
Processing 00000000.tx.205: Nuclei were collected by centrifugation at 6000g for 1min and the nuclear pellet was resuspended in 5pcv of buffer D containing 20mM Hepes pH 7.9, 1.5mM MgCl2, 0.2mM EDTA, 20% glycerol, 0.42M KCl and freshly added 1mM DTT, 1mM PMSF, 1xprotease inhibitor complete (Roche) and phosphatase inhibitors (Sigma). 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "at 6000g"

Phrase: "for 1min"

Phrase: "and"

Phrase: "the nuclear pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 5pcv of buffer D containing 20mM Hepes pH 7.9,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C1882074:pH 7 [Qualitative Concept]
   751   C0492253:PH BUFFER [Medical Device]
   751   C1512022:Ph.D. [Intellectual Product]
   736   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   736   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   736   C0020283:[pH] [Quantitative Concept]
   736   C0332256:Containing [Functional Concept]
   736   C0450407:ph+ [Finding]
   736   C0450408:ph++ [Finding]
   736   C0450409:ph+++ [Finding]
   736   C2700400:Containing [Activity]

Phrase: "1.5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.2mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "20% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "0.42M KCl"

Phrase: "and"

Phrase: "freshly added 1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM PMSF,"

Phrase: "1xprotease inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "complete"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205197:Complete [Qualitative Concept]
  1000   C0725685:COMPLEAT [Food]
   928 E C0439812:Completeness [Qualitative Concept]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: "and"

Phrase: "phosphatase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.206: The suspension was incubated on ice for 20min and insoluble debris were pelleted by centrifugation at 10000g for 2min at 4C. 

Phrase: "The suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038960:Suspension [Biomedical or Dental Material]
  1000   C1382107:Suspension [Substance]
  1000   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 20min"

Phrase: "and"

Phrase: "insoluble debris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]

Phrase: "were"

Phrase: "pelleted by centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "at 10000g"

Phrase: "for 2min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.207: Nuclear extracts were divided in aliquots and stored at -80C. 

Phrase: "Nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "divided in aliquots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332849:Divided [Functional Concept]
   756   C1510844:Aliquot [Quantitative Concept]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80C."
Processing 00000000.tx.208: The protein concentration of the extracts was determined using a Bradford assay (Bio-Rad, Munich, Germany). 

Phrase: "The protein concentration of the extracts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]
   731   C1720005:Concentrated extract [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bradford assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(Bio-Rad,"

Phrase: "Munich,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.209: Electrophoretic mobility shift assays DIG-labelled single strand oligonucleotides with different lengths were designed spanning the PSEN1 -22 promoter variation: -43-6C, 5'-ccgtgggccggccgccaacgaCgccagagccggaaatg-3'; 

Phrase: "Electrophoretic mobility shift assays DIG-labelled single strand oligonucleotides with different lengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the PSEN1 -22 promoter variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205419:Variation [Qualitative Concept]

Phrase: ": -"

Phrase: "43-6C,"

Phrase: "5'-ccgtgggccggccgccaacgaCgccagagccggaaatg-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.210: -43-6T, 5'-ccgtgggccggccgccaacgaTgccagagccggaaatg-3'; 

Phrase: "-43-6T,"

Phrase: "5'-ccgtgggccggccgccaacgaTgccagagccggaaatg-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.211: -26+1C, 5'-acgaCgccagagccggaaatgacgaca-3' and -26+1T, 5'-acgaTgccagagccggaaatgacgaca-3' and HPLC-purified. 

Phrase: "-26+1C,"

Phrase: "5'-acgaCgccagagccggaaatgacgaca-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and -"

Phrase: "26+1T,"

Phrase: "5'-acgaTgccagagccggaaatgacgaca-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "HPLC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "purified."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]
Processing 00000000.tx.212: Blunt-ended double stranded probes were obtained by annealing of the oligonucleotides with their respective reverse complements and checked on a non-denaturing 15% polyacrylamide gel in 0.25xTBE. 

Phrase: "Blunt-ended double stranded probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   836   C0441087:Double probe [Medical Device]
   804   C0182400:Probes [Medical Device]
   771 E C1704681:Probe [Gene or Genome]
   771 E C2347609:Probe [Chemical Viewed Functionally]
   771 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "obtained by annealing of the oligonucleotides"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "with their respective reverse complements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0009498:complements [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "checked on a non-denaturing 15% polyacrylamide gel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C1283174:Checked [Activity]
   744   C1382104:Gel [Substance]
   744   C1518422:Non [Functional Concept]

Phrase: "in 0.25xTBE."
Processing 00000000.tx.213: For the binding reactions 3060fmol DIG-labelled double stranded probe were added to a total reaction volume of 20l containing 210g nuclear extract, 1xHepes binding buffer (12% glycerol, 20mM HEPES or Tris, 50mM KCl, 1mM EDTA, 1mM DTT, 1mM PMSF) and 1g poly (dAdT) (Boehringer-Mannheim, Germany). 

Phrase: "For the binding reactions 3060fmol DIG-labelled double stranded probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C0441087:Double probe [Medical Device]
   793   C0182400:Probe [Medical Device]
   793   C1704681:Probe [Gene or Genome]
   793   C2347609:Probe [Chemical Viewed Functionally]
   793   C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "added to a total reaction volume of 20l containing 210g nuclear extract,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   753   C1518434:Nuclear Extract [Biomedical or Dental Material]
   751   C0449468:Total Volume [Quantitative Concept]
           *Volume
   736   C0332256:Containing [Functional Concept]
   736   C0439175:% total [Quantitative Concept]
   736   C0439810:Total [Qualitative Concept]
   736   C0443286:Reaction [Functional Concept]
   736   C0521447:Nuclear [Spatial Concept]
   736   C1114821:Reaction [Clinical Attribute]
   736   C1524062:Added [Functional Concept]
   736   C1690016:% volume [Qualitative Concept]
   736   C1705102:Volume [Intellectual Product]
   736   C2700258:Volume [Laboratory Procedure]
   736   C2700400:Containing [Activity]
   736   C2828366:Extract [Substance]
   703 E C1883712:Add [Functional Concept]

Phrase: "1xHepes"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(12% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "20mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
  1000   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
  1000   C0814229:TRI [Intellectual Product]

Phrase: "50mM KCl,"

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM PMSF"

Phrase: ")"

Phrase: "and"

Phrase: "1g poly (dAdT) (Boehringer-Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.214: For competition assays unlabelled double stranded probes were added to the reaction mixture prior to addition of the labelled probe. 

Phrase: "For competition assays unlabelled double stranded probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   822   C0441087:Double probe [Medical Device]
   799   C0182400:Probes [Medical Device]
   766 E C1704681:Probe [Gene or Genome]
   766 E C2347609:Probe [Chemical Viewed Functionally]
   766 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "added to the reaction mixture"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439962:Mixture [Substance]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "prior to addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of the labelled probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.215: In the supershift experiments the extracts were pre-incubated on ice with rabbit polyclonal anti-Ets-1/Ets-2 (SC-112X; Santa Cruz Inc., CA, USA). 

Phrase: "In the supershift experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "the extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "pre-incubated on ice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020746:Ice [Inorganic Chemical]
   770   C0332152:Pre [Temporal Concept]
   770   C0740175:Pre [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2257086:PRE [Genetic Function]

Phrase: "with rabbit polyclonal anti-Ets-1/Ets-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0812201:ETS-1 [Gene or Genome]
   795   C0034493:Rabbit [Mammal]

Phrase: "(SC-112X"

Phrase: "; Santa Cruz Inc.,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.216: The binding reactions were incubated at room temperature for 1525min. 

Phrase: "The binding reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "for 1525min."
Processing 00000000.tx.217: ProteinDNA complexes were analysed by electrophoresis on non-denaturing 6% polyacrylamide gels in 0.25xTBE and visualized by chemiluminescent detection using the DIG gel shift kit (Roche).  

Phrase: "ProteinDNA complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "analysed by electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "on non-denaturing 6% polyacrylamide gels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   804   C0017243:Gels [Biomedical or Dental Material]
   804   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   771 E C1382104:Gel [Substance]

Phrase: "in 0.25xTBE"

Phrase: "and"

Phrase: "visualized by chemiluminescent detection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0234621:Visualized [Functional Concept]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the DIG gel shift kit (Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0331965:Roche [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.218: ACKNOWLEDGEMENTS  We thank Cold Spring Harbor Laboratories for the technical support in the modified Dignam procedure for preparation of nuclear extracts. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Cold Spring Harbor Laboratories for the technical support"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0022877:Laboratories [Manufactured Object,Organization]
   744   C1619828:Laboratories [Intellectual Product]
   711 E C3244292:laboratory [Functional Concept]

Phrase: "in the modified Dignam procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "for preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of nuclear extracts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]
Processing 00000000.tx.219: We are grateful to Ayodeji Asuni for the supply of the primary neurons. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Ayodeji Asuni"

Phrase: "for the supply"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0243163:supply [Idea or Concept]
  1000   C0699914:supply [Quantitative Concept]
  1000   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
  1000   C1561604:supply [Functional Concept]
  1000   C1875802:SUPPLY [Medical Device]
  1000   C1999230:Supply [Activity]

Phrase: "of the primary neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.220: This work was supported by the Fund for Scientific Research-Flanders (Belgium; FWO-V), the Medical Foundation Queen Elisabeth, the Interuniversity Attraction Poles (IUAP) program P5/19 of the Federal Office of Scientific, Technical and Cultural Affairs (OSTC), the International Alzheimer's Research Foundation (IARF), Belgium; 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Fund"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0016820:Fund [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "for Scientific Research-Flanders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1875156:Flanders [Inorganic Chemical,Pharmacologic Substance]
   734   C0683933:scientific research [Research Activity]

Phrase: "(Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "; FWO-V),"

Phrase: "the Medical Foundation Queen Elisabeth,"

Phrase: "the Interuniversity Attraction Poles (IUAP)"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0337815:Poles [Population Group]
   793 E C0935623:Pole [Body Location or Region]
   793 E C1418729:POLE [Gene or Genome]
   743 E C0813983:polar [Quantitative Concept]
   721 E C0596963:Polarity [Quantitative Concept]

Phrase: "program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "P5/19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538611:P5 [Gene or Genome]
   861   C1539371:p5 [Gene or Genome]

Phrase: "of the Federal Office of Scientific, Technical and Cultural Affairs (OSTC),"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0010453:Cultural [Idea or Concept]
   790   C0036397:Scientific [Occupation or Discipline]
   790   C0332285:Of [Spatial Concept]
   790   C0442603:Office [Manufactured Object]
   790   C0449851:Technical [Functional Concept]
   718 E C0220814:culture [Functional Concept]
   718 E C0430400:Culture [Laboratory Procedure]
   718 E C2242979:Culture [Laboratory Procedure]

Phrase: "the International Alzheimer's Research Foundation (IARF),"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ";"
Processing 00000000.tx.221: and the Welcome Trust, UK. 

Phrase: "and"

Phrase: "the Welcome Trust,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237935:Trust [Individual Behavior]
   861   C3245466:trust [Idea or Concept]

Phrase: "UK."
Processing 00000000.tx.222: M.C. and J.T. are postdoctoral fellows of the FWO-V.  

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "J.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "postdoctoral fellows of the FWO-V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   773   C0586917:Postdoctoral Fellow [Professional or Occupational Group]
Processing 00000000.tx.223: FOOTNOTES  * To whom correspondence should be addressed at: Department of Molecular Genetics (VIB8), University of Antwerp (UIA), Universiteitsplein 1, B-2610 Antwerpen, Belgium. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Molecular Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587466:Genetics department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "(VIB8"

Phrase: ")"

Phrase: ","

Phrase: "University of Antwerp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "(UIA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ","

Phrase: "Universiteitsplein 1,"

Phrase: "B-2610 Antwerpen,"

Phrase: "Belgium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]
Processing 00000000.tx.224: Tel: +32 38202601; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+32 38202601"

Phrase: ";"
Processing 00000000.tx.225: Fax: +32 38202541; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+32 38202541"

Phrase: ";"
Processing 00000000.tx.226: Email: christine.vanbroeckhoven{at}ua.ac.be  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Slooter, A.J. and van Duijn, C.M. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "christine.vanbroeckhoven{at}ua.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1412573:AC [Gene or Genome]
   804   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   804   C3539770:AC [Gene or Genome]

Phrase: "be"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Slooter,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "van Duijn,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.227: (1997) Genetic epidemiology of Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genetic epidemiology of Alzheimer disease."
Meta Candidates (Total=16; Excluded=9; Pruned=0; Remaining=7)
   806   C0872180:Genetic Epidemiology [Occupation or Discipline]
   797   C0019247:Genetic disease [Disease or Syndrome]
   760   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   760   C0014508:epidemiology [Functional Concept]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C0699910:epidemiology [Health Care Activity]
   756 E C2316203:Genetic diseases [Finding]
   756 E C2924406:Genetic diseases [Laboratory Procedure]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.228: Epidemiol. 

Phrase: "Epidemiol."
Processing 00000000.tx.229: Rev., 19, 107119.[ISI][Medline] Cruts, M., van Duijn, C.M., Backhovens, H., Van den Broeck, M., Wehnert, A., Serneels, S., Sherrington, R., Hutton, M., Hardy, J., St George-Hyslop, P.H. et al. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "19,"

Phrase: "107119."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Van den Broeck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Serneels,"

Phrase: "S."

Phrase: ","

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.H. et al."
Processing 00000000.tx.230: (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Estimation of the genetic contribution of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0680844:estimation [Mental Process]
   744   C0681916:Estimation [Quantitative Concept]
   744   C0750572:Estimation [Quantitative Concept]

Phrase: "and -"

Phrase: "2 mutations in a population-based study of presenile Alzheimer disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0026882:Mutations [Genetic Function]
   704 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.231: Hum. 

Phrase: "Hum."
Processing 00000000.tx.232: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.233: Genet., 7, 4351.[Abstract/Free FullText] Campion, D., Flaman, J.M., Brice, A., Hannequin, D., Dubois, B., Martin, C., Moreau, V., Charbonnier, F., Didierjean, O. and Tardieu, S. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "4351."

Phrase: "[Abstract/Free FullText"

Phrase: "] Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Flaman,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Hannequin,"

Phrase: "D."

Phrase: ","

Phrase: "Dubois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Moreau,"

Phrase: "V.,"

Phrase: "Charbonnier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Didierjean,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Tardieu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.234: (1995) Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mutations of the presenilin I gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with early-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.235: Hum Mol. 

Phrase: "Hum Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.236: Genet, 4, 23732377.[Abstract] Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L. et al. 

Phrase: "Genet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "23732377."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L. et al."
Processing 00000000.tx.237: (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Segregation of a missense mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "with familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.238: Nature, 349, 704706.[CrossRef][ISI][Medline] Hutton, M., Busfield, F., Wragg, M., Crook, R., Perez-Tur, J., Clark, R.F., Prihar, G., Talbot, C., Phillips, H., Wright, K. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "349,"

Phrase: "704706."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Busfield,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Clark,"

Phrase: "R.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Phillips,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "K. et al."
Processing 00000000.tx.239: (1996) Complete analysis of the presenilin 1 gene in families with early onset Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "analysis of the presenilin 1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with early onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.240: Neuroreport, 7, 801805.[ISI][Medline] Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.-E., Jondro, P.D., Schmidt, S.D., Wang, K. et al. 

Phrase: "Neuroreport,"

Phrase: "7,"

Phrase: "801805."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "W.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.-E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "K. et al."
Processing 00000000.tx.241: (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Candidate gene for the chromosome 1 familial Alzheimer's disease locus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Gene
   757   C1708726:Gene Locus [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   730   C1416989:MAL gene [Gene or Genome]
   722   C1517488:Gene Family [Gene or Genome]
Processing 00000000.tx.242: Science, 269, 973977.[ISI][Medline] Slooter, A.J., Cruts, M., Kalmijn, S., Hofman, A., Breteler, M.M., Van Broeckhoven, C. and van Duijn, C.M. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "269,"

Phrase: "973977."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Slooter,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Kalmijn,"

Phrase: "S."

Phrase: ","

Phrase: "Hofman,"

Phrase: "A.,"

Phrase: "Breteler,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Van Broeckhoven,"

Phrase: "C."

Phrase: "and"

Phrase: "van Duijn,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.243: (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Risk estimates of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1519101:Risk Estimate [Quantitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C0750572:estimates [Quantitative Concept]

Phrase: "by apolipoprotein E genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from a population-based incidence study"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1709599:Population Based Study [Research Activity]
   902   C0681876:Population Study [Research Activity]
   861   C0021150:Study, Incidence [Quantitative Concept]
   812   C0021149:Incidence [Quantitative Concept]
   812   C0220856:incidence [Functional Concept]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
   741 E C1551358:incident [Idea or Concept]

Phrase: ":"

Phrase: "the Rotterdam Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.244: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.245: Neurol., 55, 964968.[Abstract/Free FullText] van Duijn, C.M., de Knijff, P., Cruts, M., Wehnert, A., Havekes, L.M., Hofman, A. and Van Broeckhoven, C. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "964968."

Phrase: "[Abstract/Free FullText"

Phrase: "] van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "de Knijff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Havekes,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.246: (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E4 allele in a population-based study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]

Phrase: "of early-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.247: Nat. 

Phrase: "Nat."
Processing 00000000.tx.248: Genet., 7, 7478.[ISI][Medline] Cruts, M. and Van Broeckhoven, C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "7478."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cruts,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.249: (1998) Presenilin mutations in Alzheimer's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Presenilin mutations in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.250: Hum. 

Phrase: "Hum."
Processing 00000000.tx.251: Mutat., 11, 183190.[CrossRef][ISI][Medline] Theuns, J. and Van Broeckhoven, C. 

Phrase: "Mutat.,"

Phrase: "11,"

Phrase: "183190."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Theuns,"

Phrase: "J."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.252: (2000) Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Transcriptional regulation of Alzheimer's disease genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1158770:Transcriptional Regulation [Genetic Function]
   786   C1710463:Transcription Regulation Gene [Gene or Genome]
   783   C0017263:genes regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "implications for susceptibility."
Processing 00000000.tx.253: Hum. 

Phrase: "Hum."
Processing 00000000.tx.254: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.255: Genet., 9, 23832394.[Abstract/Free FullText] Refolo, L.M., Eckman, C., Prada, C.M., Yager, D., Sambamurti, K., Mehta, N., Hardy, J. and Younkin, S.G. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "23832394."

Phrase: "[Abstract/Free FullText"

Phrase: "] Refolo,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Prada,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Sambamurti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mehta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: (1999) Antisense-induced reduction of presenilin 1 expression selectively increases the production of amyloid beta42 in transfected cells. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Antisense-induced reduction of presenilin 1 expression selectively"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the production of amyloid beta42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "in transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.257: J. 

Phrase: "J."
Processing 00000000.tx.258: Neurochem., 73, 23832388.[CrossRef][ISI][Medline] De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K. and Van Leuven, F. 

Phrase: "Neurochem.,"

Phrase: "73,"

Phrase: "23832388."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guhde,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Von Figura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.259: (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Deficiency of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011155:Deficiency [Functional Concept]
   770   C0162429:Deficiency [Disease or Syndrome]
   770   C1623416:deficiency [Qualitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the normal cleavage of amyloid precursor protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
Processing 00000000.tx.260: Nature, 391, 387390.[CrossRef][ISI][Medline] van Duijn, C.M., Cruts, M., Theuns, J., Van Gassen, G., Backhovens, H., Van den Broeck, M., Wehnert, A., Serneels, S., Hofman, A. and Van Broeckhoven, C. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "391,"

Phrase: "387390."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Theuns,"

Phrase: "J.,"

Phrase: "Van Gassen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Van den Broeck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Serneels,"

Phrase: "S."

Phrase: ","

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.261: (1999) Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genetic association of the presenilin-1 regulatory region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1328885:genetic association [Occupation or Discipline]
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with early-onset Alzheimer's disease"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "in a population-based sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.262: Eur. 

Phrase: "Eur."
Processing 00000000.tx.263: J. 

Phrase: "J."
Processing 00000000.tx.264: Hum. 

Phrase: "Hum."
Processing 00000000.tx.265: Genet., 7, 801806.[CrossRef][ISI][Medline] Pastorcic, M. and Das, H.K. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "801806."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pastorcic,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "H.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.266: (1999) An upstream element containing an ETS binding site is crucial for transcription of the human presenilin-1 gene. 

Phrase: "(1999"

Phrase: ")"

Phrase: "An upstream element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an ETS binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "crucial for transcription of the human presenilin-1 gene."
Processing 00000000.tx.267: J. 

Phrase: "J."
Processing 00000000.tx.268: Biol. 

Phrase: "Biol."
Processing 00000000.tx.269: Chem., 274, 2429724307.[Abstract/Free FullText] Rogaev, E.I., Sherrington, R., Wu, C., Levesque, G., Liang, Y., Rogaeva, E.A., Ikeda, M., Holman, K., Lin, C., Lukiw, W.J. et al. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "2429724307."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lukiw,"

Phrase: "W.J. et al."
Processing 00000000.tx.270: (1997) Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Analysis of the 5' sequence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "genomic structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "alternative splicing of the presenilin-1 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002345:Alternative Splicing [Genetic Function]
   774   C0017365:gene splicing [Gene or Genome]
   774   C0017387:Gene Splicing [Molecular Biology Research Technique]
   748   C0035687:Splicing [Genetic Function]
   748   C2610186:splicing [Genetic Function]

Phrase: "(PSEN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "associated with early onset Alzheimer's disease."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   901   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C1833334:Early-onset [Finding]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.271: Genomics, 40, 415424.[CrossRef][ISI][Medline] Theuns, J., Del-Favero, J., Dermaut, B., van Duijn, C.M., Backhovens, H., Van den Broeck, M., Serneels, S., Corsmit, E., Van Broeckhoven, C. and Cruts, M. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "415424."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Theuns,"

Phrase: "J.,"

Phrase: "Del-Favero,"

Phrase: "J.,"

Phrase: "Dermaut,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Van den Broeck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Serneels,"

Phrase: "S."

Phrase: ","

Phrase: "Corsmit,"

Phrase: "E.,"

Phrase: "Van Broeckhoven,"

Phrase: "C."

Phrase: "and"

Phrase: "Cruts,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.272: (2000) Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Genetic variability in the regulatory region of presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2827666:Variability [Conceptual Entity]

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "variable expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1868500:Variable expression [Finding]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.273: Hum. 

Phrase: "Hum."
Processing 00000000.tx.274: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.275: Genet., 9, 325331.[Abstract/Free FullText] Theuns, J., Cruts, M., Remacle, J.E., Corsmit, E., Huylebroeck, D. and Van Broeckhoven, C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "325331."

Phrase: "[Abstract/Free FullText"

Phrase: "] Theuns,"

Phrase: "J.,"

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Remacle,"

Phrase: "J.E.,"

Phrase: "Corsmit,"

Phrase: "E.,"

Phrase: "Huylebroeck,"

Phrase: "D."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.276: Variable neuron-specific presenilin 1 transcription increases risk for Alzheimer's disease. 

Phrase: "Variable neuron-specific presenilin 1 transcription increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0442805:increases [Functional Concept]

Phrase: "risk for Alzheimer's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.277: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.278: Aging, 21, S113. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "21,"

Phrase: "S113."
Processing 00000000.tx.279: Lambert, J.C., Mann, D.M., Harris, J.M., Chartier-Harlin, M.C., Cumming, A., Coates, J., Lemmon, H., StClair, D., Iwatsubo, T. and Lendon, C. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Mann,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Harris,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Chartier-Harlin,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cumming,"

Phrase: "A.,"

Phrase: "Coates,"

Phrase: "J.,"

Phrase: "Lemmon,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "StClair,"

Phrase: "D."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Lendon,"

Phrase: "C."
Processing 00000000.tx.280: (2001) The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The -48 C/T polymorphism in the presenilin 1 promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with an increased risk of developing Alzheimer's disease"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   762   C0243083:associated disease [Pathologic Function]
   762   C1281905:disease risk [Finding]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   715   C0277564:Acquired disease [Disease or Syndrome]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "an increased Abeta load in brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550025:Load [Idea or Concept]
   753   C1704782:Load [Manufactured Object]
   753   C1708715:Load [Activity]
Processing 00000000.tx.281: J. 

Phrase: "J."
Processing 00000000.tx.282: Med. 

Phrase: "Med."
Processing 00000000.tx.283: Genet., 38, 353355.[Abstract/Free FullText] Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "38,"

Phrase: "353355."

Phrase: "[Abstract/Free FullText"

Phrase: "] Quandt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Frech,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Karas,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wingender,"

Phrase: "E."

Phrase: "and"

Phrase: "Werner,"

Phrase: "T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.284: (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. 

Phrase: "(1995"

Phrase: ")"

Phrase: "MatInd"

Phrase: "and"

Phrase: "MatInspector"

Phrase: ":"

Phrase: "new fast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015663:Fast [Finding]
   861   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "versatile tools for detection of consensus matches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0336791:Tool [Manufactured Object]
   714   C2827396:Tool [Manufactured Object]

Phrase: "in nucleotide sequence data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0004793:Nucleotide Sequence [Nucleotide Sequence]
Processing 00000000.tx.285: Nucl. 

Phrase: "Nucl."
Processing 00000000.tx.286: Acids Res., 23, 48784884.[Abstract] Fornasari, D., Battaglioli, E., Flora, A., Terzano, S. and Clementi, F. 

Phrase: "Acids Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "48784884."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fornasari,"

Phrase: "D."

Phrase: ","

Phrase: "Battaglioli,"

Phrase: "E.,"

Phrase: "Flora,"

Phrase: "A.,"

Phrase: "Terzano,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Clementi,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.287: (1997) Structural and functional characterization of the human alpha3 nicotinic subunit gene promoter. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional characterization of the human alpha3 nicotinic subunit gene promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]
Processing 00000000.tx.288: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.289: Pharmac., 51, 250261.[Abstract/Free FullText] Farrer, M., Maraganore, D.M., Lockhart, P., Singleton, A., Lesnick, T.G., de Andrade, M., West, A., de Silva, R., Hardy, J. and Hernandez, D. 

Phrase: "Pharmac.,"

Phrase: "51,"

Phrase: "250261."

Phrase: "[Abstract/Free FullText"

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Lockhart,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Lesnick,"

Phrase: "T.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "de Andrade,"

Phrase: "M."

Phrase: ","

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.,"

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Hernandez,"

Phrase: "D."
Processing 00000000.tx.290: (2001) alpha-Synuclein gene haplotypes are associated with Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "alpha-Synuclein gene haplotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0018591:Haplotypes [Organism Attribute]
   756   C1420276:alpha synuclein gene [Gene or Genome]
   756   C2983377:Alpha-Synuclein Gene [Gene or Genome]
   708   C1537647:ALPHA GENE [Gene or Genome]
   708   C2985256:Alpha Gene [Gene or Genome]

Phrase: "are"

Phrase: "associated with Parkinson's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.291: Hum. 

Phrase: "Hum."
Processing 00000000.tx.292: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.293: Genet., 10, 18471851.[Abstract/Free FullText] Artiga, M.J., Bullido, M.J., Sastre, I., Recuero, M., Garcia, M.A., Aldudo, J., Vazquez, J. and Valdivieso, F. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "18471851."

Phrase: "[Abstract/Free FullText"

Phrase: "] Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Sastre,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Recuero,"

Phrase: "M."

Phrase: ","

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Aldudo,"

Phrase: "J.,"

Phrase: "Vazquez,"

Phrase: "J."

Phrase: "and"

Phrase: "Valdivieso,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.294: (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   754   C0678951:gene polymorphisms [Genetic Function]
   738   C0032529:polymorphisms [Genetic Function]
   704 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.295: FEBS Lett., 421, 105108.[CrossRef][ISI][Medline] Chiba-Falek, O. and Nussbaum, R.L. 

Phrase: "FEBS Lett.,"

Phrase: "421,"

Phrase: "105108."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chiba-Falek,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.296: (2001) Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Effect of allelic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "at the NACP-Rep1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413394:REP-1 [Gene or Genome]

Phrase: "repeat upstream of the alpha-synuclein gene"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C1420276:alpha synuclein gene [Gene or Genome]
           SYNUCLEIN, ALPHA
   814   C2983377:Alpha-Synuclein Gene [Gene or Genome]
   778   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1537647:ALPHA GENE [Gene or Genome]
   774   C2985256:Alpha Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205341:Repeat [Functional Concept]
   748   C0439095:Alpha [Intellectual Product]
   748   C0522505:Upstream [Spatial Concept]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]
   748   C2003941:Alpha [Intellectual Product]
   748   C2350010:Alpha [Qualitative Concept]

Phrase: "(SNCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0285890:SNCA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SNCA [Gene or Genome]

Phrase: ")"

Phrase: "on transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "in a cell culture luciferase reporter system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   885   C1516329:Cell Culture System [Molecular Biology Research Technique]
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.297: Hum. 

Phrase: "Hum."
Processing 00000000.tx.298: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.299: Genet., 10, 31013109.[Abstract/Free FullText] Riazanskaia, N., Lukiw, W.J., Grigorenko, A., Korovaitseva, G., Dvoryanchikov, G., Moliaka, Y., Nicolaou, M., Farrer, L., Bazan, N.G. and Rogaev, E. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "31013109."

Phrase: "[Abstract/Free FullText"

Phrase: "] Riazanskaia,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lukiw,"

Phrase: "W.J.,"

Phrase: "Grigorenko,"

Phrase: "A.,"

Phrase: "Korovaitseva,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dvoryanchikov,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moliaka,"

Phrase: "Y.,"

Phrase: "Nicolaou,"

Phrase: "M."

Phrase: ","

Phrase: "Farrer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bazan,"

Phrase: "N.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Rogaev,"

Phrase: "E."
Processing 00000000.tx.300: (2002) Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Regulatory region variability in the human presenilin-2 (PSEN2) gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C0598666:variable region gene [Gene or Genome]
   742   C2827666:Variability [Conceptual Entity]

Phrase: ":"

Phrase: "potential contribution to the gene activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "risk for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.301: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.302: Psychiat., 7, 891898.[CrossRef][ISI] Schoenherr, C.J. and Anderson, D.J. 

Phrase: "Psychiat.,"

Phrase: "7,"

Phrase: "891898."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Schoenherr,"

Phrase: "C.J."

Phrase: "and"

Phrase: "Anderson,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.303: (1995) The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The neuron-restrictive silencer factor (NRSF)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0295893:neuron restrictive silencer factor [Amino Acid, Peptide, or Protein]
  1000   C1419346:NEURON-RESTRICTIVE SILENCER FACTOR [Gene or Genome]
   812   C0027882:Neuron [Cell]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   741 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "a coordinate repressor of multiple neuron-specific genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.304: Science, 267, 13601363.[ISI][Medline] Chong, J.A., Tapia-Ramirez, J., Kim, S., Toledo-Aral, J.J., Zheng, Y., Boutros, M.C., Altshuller, Y.M., Frohman, M.A., Kraner, S.D. and Mandel, G. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "267,"

Phrase: "13601363."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chong,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Tapia-Ramirez,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Toledo-Aral,"

Phrase: "J.J.,"

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "Y.,"

Phrase: "Boutros,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Altshuller,"

Phrase: "Y."

Phrase: "M."

Phrase: ","

Phrase: "Frohman,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kraner,"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Mandel,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.305: (1995) REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. 

Phrase: "(1995"

Phrase: ")"

Phrase: "REST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: ":"

Phrase: "a mammalian silencer protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "restricts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:restrict [Functional Concept]

Phrase: "sodium channel gene expression to neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.306: Cell, 80, 949957.[ISI][Medline] Theuns, J., Cruts, M., Del-Favero, J., Goossens, D., Dauwerse, H., Wehnert, A., den Dunnen, J.T. and Van Broeckhoven, C. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "80,"

Phrase: "949957."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Theuns,"

Phrase: "J.,"

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Del-Favero,"

Phrase: "J.,"

Phrase: "Goossens,"

Phrase: "D."

Phrase: ","

Phrase: "Dauwerse,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "den Dunnen,"

Phrase: "J.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.307: (1999) Determination of the genomic organization of human presenilin 1 by fiber-FISH analysis and restriction mapping of cloned DNA. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Determination of the genomic organization of human presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1148554:determination [Laboratory Procedure]

Phrase: "by fiber-FISH analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1517169:Fiber FISH [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "restriction mapping of cloned DNA."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0035269:Restriction Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   797   C1328871:DNA mapping [Intellectual Product]
   797   C1749889:DNA restriction [Genetic Function]
   760   C0443288:Restriction [Functional Concept]
   760   C1283195:Mapping [Activity]
   726 E C0024779:Map [Manufactured Object]
   726 E C1706473:Map [Conceptual Entity]
Processing 00000000.tx.308: Mamm. 

Phrase: "Mamm."
Processing 00000000.tx.309: Genome, 10, 410414.[CrossRef][ISI][Medline] Thinakaran, G., Teplow, D.B., Siman, R., Greenberg, B. and Sisodia, S.S. 

Phrase: "Genome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "10,"

Phrase: "410414."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.310: (1996) Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Metabolism of the ""Swedish"" amyloid precursor protein variant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C1327340:amyloid precursor protein metabolism [Molecular Function]
   767   C0597299:Protein Metabolism [Molecular Function]
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]

Phrase: "in neuro2a (N2a) cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.311: Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that cleavage at the ""beta-secretase"" site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "occurs in the golgi apparatus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   760   C0243111:apparatus [Manufactured Object]
   760   C1709305:Occur [Activity]
   760   C1947951:Apparatus [Anatomical Structure]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.312: J. 

Phrase: "J."
Processing 00000000.tx.313: Biol. 

Phrase: "Biol."
Processing 00000000.tx.314: Chem., 271, 93909397.[Abstract/Free FullText] Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "271,"

Phrase: "93909397."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dignam,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Lebovitz,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Roeder,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.315: (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Accurate transcription initiation by RNA polymerase II"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1158830:Transcription Initiation [Genetic Function]
           Initiation
   748   C0589507:Initiation [Mental Process]
   748   C1704686:Initiation [Functional Concept]

Phrase: "in a soluble extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "from isolated mammalian nuclei."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.316: Nucl. 

Phrase: "Nucl."
Processing 00000000.tx.317: Acids Res., 11, 14751489.[Abstract]

Phrase: "Acids Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "11,"

Phrase: "14751489."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

